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be  directly  induced  by  oxidizing  agents  and  inhibited  by  PKCβ  siRNA  silencing.  The 
differentiated  adipocytes, when  implanted  in  vivo,  form  viable  and  vascularized  adipose 
tissue.  
Overall, the data highlight a previously uncharacterized differentiation route triggered by 
high  glucose  that  drives  not  only  resident  stem  cells  of  the  adipose  tissue  but  also 
uncommitted precursors present  in muscle cells  to  form adipose depots. This process may 













Adipose  tissue  is  a  heterogeneous  organ  constituted  by many  fat  depots  differently 
located  in  the body. Mechanical support  is given by  fat pads  located  in  the heels,  in  the 
fingers,  in  the  toes  and  in  the  periorbital  region.  Adipocytes  are  found  also  in  the 
subcutaneous layers between the muscle and dermis, commonly known as subcutaneous 
adipose  tissue  (SAT), while some adipose depots are within  the body cavity, around  the 
heart,  kidneys,  and  other  internal  organs,  associated  with  the  mesentery  or  in  the 
retroperitoneum  and  represent  the  visceral  fat  (VAT)  [1]. VAT  comprises  omental  and 
mesenteric deposits and represents 10–20% of total body fat in thin and obese men, and 5–
10% of total body fat in women, while SAT represents 80% of a healthy individual’s total 
fat  mass.  In  addition,  a  further  distinction  can  be  made  between  brown  and  white 
adipocytes, constituting functional and morphologically different tissues, Brown Adipose 
Tissue (BAT) and White Adipose Tissue (WAT), respectively. Brown adipocytes are found 
only  in  mammals,  and  are  multilocular  and  contain  less  overall  lipid  than  white 
adipocytes,  and  are  particularly  rich  in mitochondria.  Furthermore,  brown  adipocytes 




While  rodents  have  a distinct  brown  fat pad, which  lies  in  the  interscapular  region,  in 
humans  brown  adipose  tissue  surrounds  the  heart  and  great  vessels  in  infancy  but 
disappears during growth until only scattered cells can be found within white fat pads. 
Adipose  tissue  has  been  considered  an  energy  storage  depot  with  few  interesting 
attributes. The past  two decades, however, have  seen an  increasing  scientific  interest  in 
this tissue, triggered by evidences about its strong correlation with Obesity and Metabolic 
Syndrome, and also by  the  recognition  that,  further  than  the key  role  in  controlling  the 
energy metabolism  homeostasis,  adipose  tissue  integrates many  homeostatic  processes, 
such  as  immune  response,  blood  pressure,  bone mass,  haemostasis,  and  reproductive 
function  [2]. These processes are coordinated mainly through the synthesis and release of 
peptide hormones by adipocytes. 
Obesity  is  now  recognized  as  a major  health  problem,  since  it  represents  the most 
important  independent risk factor for insulin resistance, Type II Diabetes, dyslipidaemia, 
high  blood  pressure  and  thrombosis.  Increased  fat  storage  in  fully  differentiated 
adipocytes,  resulting  in  enlarged  fat  cells,  is well documented  and  is  thought  to be  the 
most  important mechanism whereby  fat depots  increase  in adults  [3]. Nevertheless,  the 







The  adipose  cells  arise  from mesoderm,  and white  adipose  tissue  formation  begins 
before birth  and proceeds  after birth, because of  increased  size of  existing  fat  cells  and 





lineage  derives  from  a  mesenchymal  multipotent  precursor,  able  to  differentiate  in 
adipocyte,  chondrocyte,  osteoblast,  fibroblast  and  myocyte.  Although  the  attempts  to 
identify  the  cellular  intermediates  between  the mesenchymal  stem  cell  and  the mature 
adipocyte,  such  intermediates have been difficult  to  characterize  at  the molecular  level. 
Nonetheless, adipogenesis can be described in two phases, as described in figure 1.  
The first phase is known as determination, and results in the conversion of the stem cell 
to a mesenchymal multipotent  intermediate, which can originate a pre‐adipocyte,  that  is 
morphologically indiscernible from its precursor but has lost the potential to differentiate 
into other cell  types.  In  the second phase,  the so‐called  terminal differentiation,  the pre‐
adipocyte  acquires  the  machinery  necessary  for  lipid  transport  and  synthesis,  insulin 
sensitivity and secretion of adipokines.  
In vitro model of differentiation and studies  in  transgenic mice are widely used  to get 
some  insight  in  the molecular mechanisms and signals  transduction pathways  involved, 
and terminal differentiation is more extensively characterized than determination, because 
























adipocyte.  Given  appropriate  environmental  stimuli,  preadipocytes  undergo  clonal  expansion  and 







embryos  [8,  9],  and  the Ob17  cell  line, derived  from  epididymal  fat pads of genetically 
obese  (ob/ob)  adult mice  [10].  Following  seeding,  cells  display  an  exponential  growth 




are morphologically  similar  to  fibroblasts. Confluent  3T3‐L1 preadipocytes differentiate 
upon  exposure  to  the  adipogenic  inducers  fetal  bovine  serum  (FBS),  dexamethasone, 
isobutylmethylxanthine  (IBMX),  and  insulin.  This  cocktail  activates  an  adipogenic 















referred  to  as  clonal  expansion. During  this  time,  the  cells  express  specific  adipogenic 
transcription  factors as well as  cell  cycle  regulators  that  together  facilitate  expression of 









Adipogenesis  in  vitro  follows  a  highly  ordered  and  well  characterized  temporal 
sequence. The  first  step  is  the growth  arrest of proliferating preadipocytes,  achieved  in 
cultured  cell  lines  after  contact  inhibition,  although  cell–cell  contact  is  not  absolutely 
required  for growth arrest  to occur  [7, 11].  In cultured preadipocyte cell  lines,  treatment 
with adipogenic hormone induces growth arrest and is followed by one or two additional 
rounds of cell division, known as clonal expansion.  
Below  is presented  an overview on  factors  and pathways  involved  in  transcriptional 
regulation of adipocyte differentiation, as extensively reviewed in [7, 12‐17]. 
Adipocyte differentiation is regulated by a network of transcriptional factors managing 
the  expression  of  hundreds  of  proteins  responsible  for  establishing  the mature  fat‐cell 
phenotype. This process is mainly regulated by three principal adipogenic factors, the key 
transcription  factors  peroxisome  proliferator‐  activated  receptor  γ  (PPARγ),  the 
CCAAT/enhancer binding protein α(C/EBPα) and  the  sterol  regulatory  element binding 
protein 1(SREBP1).  
PPARγ  is  a  member  of  the  peroxisome  proliferator  activated  receptors  (PPAR) 
subfamily of nuclear hormone receptors and was cloned independently by several groups. 
Three groups found two homologues to PPARα (then simply called PPAR) in Xenopus and 
mice,  shown  to  activate  the  acyl  CoA  oxidase  promoter  in  response  to  a  variety  of 
xenobiotic and hypolipidemic agents, and called them PPARβ (also called PPARδ, NUC‐1, 
and FAAR) and PPARγ. Looking for transcription factors promoting fat cell development, 
Spiegelman  identified  an  adipose  cell‐selective  fatty  acid  binding protein  aP2  enhancer 
and discovered that this enhancer is sufficient to direct gene expression and differentiation 







of  developing  the  adipocyte  phenotype,  and  alone  it  can  initiate  the  entire  adipogenic 
program.  In  fact,  most  pro‐adipogenic  factors  seem  to  function  at  least  in  part  by 
activating  PPARγ  expression  or  activity.  PPARγ  exists  as  two  isoforms,  PPARγ1  and 





Nuclear  hormone  receptor  superfamily  members  are  ligand‐activated  transcription 
factors, and PPARγ  is not an exception. PPARγ can be activated by synthetic compounds 
called thiazolidinediones (TZDs), which are used clinically as antidiabetic agents treating 
hyperlipidemia  and  insulin  resistance. Treatment  of preadipocytes with TZDs  increases 
both  the  extent  and  the  rate  of  adipogenesis  and  this  occurs  in  vivo  as well  as  in  vitro, 

















deficiency  resulted  in  failure  to  form  adipose  tissue,  and  the  establishment  of  white 
adipose  tissue  (WAT)‐hypomorphic  PPARγ  knockdown  mice  resulted  in  animals  that 





some  of  them,  C/EBPα,  C/EBPβ,  C/EBPγ,  C/EBPδ  and  CHOP  (transcription  factor 
homologous to CCAT‐enhancer binding protein) are expressed in adipocytes. Their tissue 
distribution  is  not  restricted  to  fat  cells,  since C/EBP  proteins  are  also  involved  in  the 
terminal differentiation of granulocytes and hepatocytes; in resistance to infection and the 
tissue  response  to  injury  in  addition  to  transactivating  a wide  variety  of  target  genes. 
Regulated expression is seen for several C/EBP family members during adipogenesis, and 
recent  gain‐  and  loss  of‐function  studies  indicate  that  these  proteins  have  a  profound 
impact  on  fat  cell  development.  In  particular, C/EBPα  is  induced  in  adipogenesis  and 
experiments of C/EBPα expression  in  fibroblasts at  levels equivalent  to  those seen  in  fat 
demonstrate that it can cooperate powerfully with PPARγ triggering adipogenesis even if 
in absence of PPARγ ligands. This ability of PPARγ and C/EBPα to promote differentiation 




PPARγ  is  the dominant  factor,  since experiments  in C  /EBPα‐deficient MEFs PPARγ can 






adipogenesis  leads to  induction of C/EBPα. These factors appear to be very  important  in 
the induction of PPARγ in adipocyte differentiation, and some data show that conditional 
expression of C/EBPβ and C/EBPδ yield expression  levels of PPARγ equivalent  to  those 
seen  in adipocytes,  indicating  that  the expression of PPARγ  is depend on C/EBPβ and  δ 
expression.  
Another  factor  that  can  co‐work  with  PPARγ  is  the  adipocyte  determination  and 
differentiation  factor  1/sterol  response  element  binding  protein  1(ADD1/SREBP1),  a 
member of  the basic helix‐loop–helix  (bHLH)  family of  transcription  factors. This  family 
has been implicated in tissue‐specific gene regulation, particularly in muscle, and SREBP1 






effect,  one  interpretation  is  that  SREBP1c  is  responsible  for generating  some  factor  that 
enhances PPARγ activity, i.e. its endogenous ligand.  
The  body  of  knowledge  concerning  all  the  events  occurring  during  adipocyte 
differentiation has led to a model for a transcriptional network (described in figure 2) but 
the scheme have to be completed by a group of protein, called nuclear cofactors, such as 
the  p160/CBP/p300  complex,  the DRIP/TRAP  complex  and  PPARγ  coactivator‐1  and  ‐2 
(PGC1 and PGC2), operates  to open up  tightly wound  chromatin  structures and  recruit 
elements of the basal transcription apparatus, in order for transcription factors to activate 
gene  expression.  The  interaction  of  multiple  coactivators  with  transcription  factors  in 















differentiation;  one major  function  of C/EBPβ  and C/EBPδ  is  to  induce  the  expression  of  PPARγ, which  in  turn 
activates  C/EBPα.  C/EBPα  exerts  positive  feedback  on  PPARγ  to maintain  the  differentiated  state.  SREBP1  can 









an  excess  of  body  fat  and  it  is  now  considered  a  public  health  problem  in  most 
economically  advanced  countries.  The  prevalence  of  the  disorder  in  the United  States 
comprises  ∼1  in  3  adults  [18].  The Obesity  epidemic  has  developed with  considerable 
rapidity over the past 2 decades, with the incidence rising 3‐fold in the U.K., for example, 
since  the early 1980s  [19]and  the problem  is not  limited  to adults, a marked  increase  in 
Obesity is found among children [20]. Obesity is associated with a reduction in life span of 
∼8 years,  as well  as with  an  increased  risk of  several major diseases,  including Type  II 
Diabetes, coronary heart disease, and certain cancers (such as breast and colon). In the case 
of  Type  II Diabetes,  the  risk  is  particularly marked  because  being  obese  increases  the 
likelihood  of  developing  the  disease  by  ∼10‐fold  once  a  BMI  of  30  kg/m2  is  reached. 
Furthermore, the greater is the degree of Obesity, the higher is the relative risk. 





those  from  lower  socio‐economic  strata  in Western  countries;  the  distribution  of  fat  is 
sexually  dimorphic:  in  general  more  subcutaneous  fat  is  found  in  women  (gynecoid 
distribution), while an  increase  in  intra‐abdominal  fat  (android distribution)  is  found  in 
men. These two types of adipose tissue present metabolically differently behaviors, since 
android  Obesity  is  strongly  associated  with  insulin  resistance  and  increased 
cardiovascular morbidity and mortality (i.e. risk of heart attacks).  
The primary  role of  adipose  tissue  is  the  control of  energy  intake  through  fatty  acid 
deposition  (as  triacylglycerols)  and  release,  and  the  apparent  simplicity  of  both white 
13 
 







retinol,  steroid  hormones,  and  prostaglandins  [21].  Cholesterol  and  retinol  are  not 
synthesized by WAT, but  rather  are  taken up  and  stored within  the  tissue,  and  steroid 
hormone  conversions  can  take  place  in  white  adipocytes  [22].  Moreover,  the  enzyme 
lipoprotein  lipase  (LPL)  is  released  from  adipocytes  for  the  breakdown  of  circulating 
triacylglycerols to FFA, which are subsequently stored within fat cells.  
Moreover, WAT  is  the primary  site of  the production of key hormones  involved not 
only  in  energy  balance,  but  also  involved  in  a  range  of  metabolic  and  physiological 
processes;  some  of  these  factors,  termed  adipokines,  are  implicated  in  the  pathologies 


















About  basal metabolic  rate,  there  is  no  evidence  that  the  obese  have  a  low  resting 






receptor defects; Pro‐opiomelanocortin cleavage defect  leading  to  loss of  the Melanocyte 
Stimulating Hormone  (MSH).  In  addition,  there  are  a  number  of  other  rare  disorders 







the  identification  of  the  hormone  leptin  in  1994, which  followed  the  search  for  the Ob 
gene, a mutation in which is responsible for the Obesity of the ob/ob mouse [25]. Leptin, a 
16  kDa  cytokine‐like  protein,  is  a  critical  hormonal  signal  from  adipocytes  in  the 
regulation of appetite and energy balance [26, 27],  interacting with several hypothalamic 
orexigenic and anorexigenic pathways.  
The  diversity  of  the  adipokines  (described  below)  secreted  by  the  adipose  tissue  in 
addition  to  leptin,  is  considerable,  in  terms of both protein  structure  and  function. The 
adipokines  (figure 3)  include classical cytokines  (e.g., TNFα,  IL6), chemokines  (monocyte 
chemoattractant  protein‐1  (MCP1)),  proteins  of  the  alternative  complement  system 
(adipsin), and proteins involved in vascular hemostasis (plasminogen activator inhibitor‐1 
(PAI1)), the regulation of blood pressure (angiotensinogen), lipid metabolism (cholesteryl 























processes  has  been  established  through  the  identification  of  leptin,  the  hormone  being 
secreted  principally  from  adipocytes,  with  actions  both  centrally  (particularly  in  the 
hypothalamus) and in peripheral organs. 
Leptin (called the Adipocyte Hormone) is the most important protein factor secreted by 
differentiated  mature  white  adipocytes  [29]  discovered  in  1994  by  Friedman  and 
colleagues  [25],  with  the  identification  of  the  mutant  gene  which  underlies  the 
development of the Obesity of the ob/ob mouse.  
The leptin gene (ob) encodes an 18 kDa protein containing a signal sequence cleaved to 
produce  the  mature  hormone  of  molecular  weight  16  kDa  [25].  Since  initial  studies 
indicates white adipose tissue as the unique site of  leptin synthesis,  it  is now recognized 






does and both  circulating  levels and adipose  tissue mRNA expression of  leptin  [31] are 
strongly associated with BMI and  fat mass  in Obesity; conversely,  transgenic mice have 
very  low circulating  leptin  levels  [32]. Thus  the circulating hormone  level  is a marker of 
total body fat mass [33, 34], where the subcutaneous fraction represents about 80% of total 
fat.  
Leptin  production  in  adipose  tissue  presents  differences  given  by  species  and 
developmental stage; in rodents the levels of ob gene expression are highest in the gonadal 
and perirenal adipose tissue of the mature animal, and lowest in the subcutaneous depots 
[35], while  in  humans  the  subcutaneous  tissue  exhibits higher  levels  of  ob mRNA  than 
omental fat [36]. Nutritional state influences leptin synthesis in adipose tissue [30]: in fact, 
ob gene expression  is suppressed by  fasting  (effect reversed on refeeding), such as acute 
exposure  to  cold  [37]  and neurotransmitters  as  catecholamines, both noradrenaline  and 
adrenaline  [30]. On  the  contrary,  several hormones  stimulate  leptin production:  insulin, 
glucocorticoids and oestrogens and cytokines as TNFα [30]. 
The hormone has an autocrine and paracrine function in adipose tissue because of the 






The  main  role  of  leptin  is  the  regulation  of  energy  homeostasis  [41]  through  its 
interaction  with  several  central  neuroendocrine  systems,  including  suppression  of 









sensitivity  and  reduces  intra‐myocellular  lipid  levels  through  a  combination  of  direct 
activation  of  AMP‐activated  protein  kinase  (AMPK)  and  indirect  actions  mediated 




Adiponectin  is a 30‐kDa protein highly expressed  in adipose  tissue, but  in contrast  to 
other adipose‐ derived  factors, adiponectin acts as an  insulin sensitizer hormone  toward 
insulin  sensitive  tissues.  It was  identified by  several different groups and given various 
names  (apM1,  GBP28,  AdipoQ  and  ACRP30)  [54]  and  circulates  at  great  high 
concentrations  (5–10  μg/ml),  accounting  for  0.01%  of  all  plasma  protein,  and  its  blood 
levels are  inversely correlated with body mass.  In  fact, adiponectin  is underexpressed  in 
obese  patients with  insulin  resistance,  Type  II Diabetes,  and  in  patients with  coronary 
heart disease, and presents an  insulin‐sensitizing effect  like  leptin, stimulating  fatty acid 
oxidation in an AMPK and PPARα ‐dependent manner [55, 56]; adiponectin is involved in 
the regulation of glucose homeostasis since it ameliorates hyperglycemia reducing hepatic 
glucose  production,  by  decreasing  the  expression  of  two  essential  gluconeogenesis 
enzymes: phosphoenolpyruvate carboxykinase  (PEPK); and glucose‐6‐phosphatase  (G6P) 
[57].  







tissues,  but Yang  et  al.  in  2005  reported RBP4  is  the  link  between Obesity  and  insulin 
resistance and defined  its  role  in  impairing  insulin sensitivity  in  insulin‐sensible  tissues, 
such  as  skeletal  muscle  and  liver  [60].  Yang  and  colleagues  generated  mice  with  an 
adipose‐specific  reduction of GLUT4  (adipose GLUT4−/− knockout mice), which develop 
liver  and  skeletal muscle  insulin  resistance.  In  this model, plasma  levels of  insulin  and 
adipokines known  to  influence  insulin sensitivity  remain normal,  thus suggesting  that a 
circulating  factor  secreted  by  adipocytes  causes  insulin  resistance  in  these mice.  RBP4 
serum  levels  are  elevated  in  insulin‐resistant  rodents,  and  in  obese  or  type  II  diabetic 
humans;  this  confirmed  that RBP4 was  the  factor  secreted by adipocytes which  reduces 
phosphatidylinositol‐3‐OH kinase (PI3K) signaling  in muscle and enhances expression of 






promote  lipid  burning  as  an  energy  source  in  most  tissues  sparing  carbohydrate  for 
neurons and red blood cells, which depend on glucose, and thus they are able to regulate 



















acid  transporters  essential  for  adipocyte  biology,  are  also  expressed  and  functional  in 
macrophages [67]. In Obesity, the inflammatory state involves not only adipose tissue, but 










A major step  forward  in  the recognition of  the secretory role of WAT occurred  in  the 
early 1990s with the discovery that the proinflammatory cytokine tumor necrosis factor‐α 
(TNFα)  is synthesized and released by adipocytes  in rodents and  in humans  [65]. TNFα 
expression  increases  in  Obesity,  and  this  cytokine  plays  an  important  role  in  the 
pathophysiology  of  insulin  resistance  (see  Introduction‐Insulin  Resistance  and  Type  II 







Secretion  of  IL6  from  adipose  tissue  is  higher  in  visceral  than  in  subcutaneous  depots 
(three times more), underlining the fundamental role of central Obesity in cardiovascular 
diseases. Moreover,  IL6  production  derives mainly  from  the  stromal  vascular  fraction 
(endothelial cells, monocytes/macrophages) rather than from adipocytes themselves [72].  
Deleterious  effects  given  by  IL6  secretion  are  due  to  its  diverse  target  tissues  and 
function. First of all, IL6 controls the hepatic production of inflammatory proteins such as 
CRP,  important  cardiovascular  risk  factor  [73].  Moreover,  IL6  produced  by  visceral 









While  levels  of  resistin  are  elevated  in many murine models  of Obesity,  the  role  of 
resistin  in  humans  remain  controversial;  data  suggest  that  it  could  be  the  product  of 
macrophages  or  other  stromal  cells within  the  fat  pad  [76]  and might  be  involved  in 
















Obesity has been  identified  as  a major  causative  factor  for  the  insulin  resistance  and 
hyperglycemia associated with Diabetes  [80], and Obesity‐induced Diabetes  is emerging 
as  a  global  health‐care  problem  reaching  epidemic  proportions  in  the  industrialized 
countries and also increasing in developing nations. Along with Diabetes, there has been a 
concomitant increase of the incidence of an Obesity‐linked condition, called the Metabolic 
Syndrome.  The  Metabolic  Syndrome  is  defined  as  a  clustering  of  diseases,  such  as 
abdominal  Obesity,  insulin  resistance,  dyslipidemia,  and  elevated  blood  pressure, 
reflecting  overnutrition  and  sedentary  lifestyles  [81],  associated  with  a  doubling  of 
cardiovascular disease risk and a 5‐fold increased risk for incident Type II Diabetes. Many 
conditions  are directly  associated with  the Metabolic  Syndrome, mainly  because  of  the 
excess  in adiposity and the  insulin resistance: Nonalcoholic fatty  liver disease, Polycystic 
ovarian  syndrome,  Obstructive  sleep  apnea,  Hypogonadism,  Lipodystrophy  and 
Microvascular disease. 






Insulin  is  the principal  hormone  of  glucose  homeostasis;  it  stimulates  glucose  influx 






The  intracellular  insulin  signal  transduction pathway  is  summarized  in  figure  4. The 
binding  of  insulin  to  the α‐subunit  of  the  insulin  receptor  (IR) molecule  induces  rapid 
autophosphorylation of the β subunit, which turns on its tyrosine kinase activity [82]. This 
gives IR the ability to phosphorylate various tyrosine residues of other cytosolic moieties, 
including  insulin  receptor  substrates  (IRS) 1 and 2. The  tyrosine phosphorylation of  IRS 
proteins  leads  to  the  second  intracellular  step  of  insulin  action,  the  association  of 
phosphorylated IRS1 or IRS2 with the enzyme phosphoinositide‐3‐kinase (PI3K). The IRS‐




















Fig.  4  Intracellular  Insulin  Signal  Transduction.  Insulin  binding  to  the  insulin  receptor  triggers  its 
autophosphorylation and catalyzes the tyrosine phosphorylation of IRS1 and 2. These IRS proteins interact 
with diverse signaling molecules, including PI3K which in turn activate Akt/PKB. The downstream proteins 





and how  insulin  resistance  causes  the onset Type  I Diabetes  through  β‐cell dysfunction 
and  glucotoxicity  is  actually  mainly  known.  β‐cells  are  responsible  for  sensing  and 
secreting the appropriate amount of insulin in response to a glucose stimulus. In healthy 
individuals, there is a feedback loop between the insulin‐sensitive tissues and the β‐cells, 
with  β‐cells  increasing  insulin  supply  in  response  to demand by  the  liver, muscles  and 
adipose tissue [90]. In the early stages of Type II Diabetes, euglycemia is maintained and 
insulin  resistance  is  countered  by  the  continuous  insulin  production  in  the  pancreas. 
Progressively,  β‐cells  fail  to  respond  adequately  to  blood  glucose  stimulation,  and  this 
importantly  contributes  to  reduce  insulin  release.  As  a  result  of  β‐cell  dysfunction, 
decreased  insulin  secretion  determinates  disordered  regulation  of  glucose  levels  by 
decreasing  suppression  of  hepatic  glucose  production  and  reducing  the  efficiency  of 
glucose  uptake  in  insulin‐sensitive  tissues. Decreased  insulin  output  could  also  impair 
adipocyte metabolism,  resulting  in  increased  lipolysis and  elevated FFA  levels. Chronic 
exposure to FFA causes a decrease in insulin secretion and this effect is mediated mainly 
by  lipotoxicity  induced  apoptosis  of  islet  cells  [91]. Moreover,  the  extremely  elevated 
blood  glucose  levels  observed  in  diabetes  contribute  to  further  disease  progression 
through glucotoxic effects on  the β‐cell. Impairments of  insulin release may have central 
effects  on  metabolic  homeostasis:  insulin  acts  in  the  hypothalamus  to  regulate  body 
weight, and impaired insulin signaling is associated with changes in food intake and body 








resistant  condition,  the pathogenesis of Obesity‐induced  insulin  resistance  itself has not 
been fully elucidated.  
As a person gains weight, adipose  tissue becomes morphologically and metabolically 
dysfunctional,  with  visceral  adipocytes  particularly  affected  [93‐95].  These  changes 
contribute  to aberrant endocrine  function, with multiple potential consequences  in  terms 
of metabolic dysfunction,  insulin resistance, and cardiovascular disease risk  [96]. Central 
appear to be some of the derangements in insulin signaling caused by the adipose tissue 
release  of  FFA,  hormones  and  proinflammatory  cytokines  [80,  97]  which  are 





inhibits  adipose  tissue  lipolysis;  however,  in  the  setting  of  insulin  resistance,  insulin  is 
unable  to properly suppress  lipolysis, resulting  in  increased circulating FFA  levels  [101]. 




Increased  intracellular  FFA  in  peripheral  tissues  might  result  in  competition  with 
glucose for substrate oxidation, leading to the serial inhibition of three key enzymes of the 
glucose  fatty‐acids cycle[103], and  in an  increase  in  the  intracellular content of  fatty acid 




ability  of  these molecules  to  activate  PI3K  [104]. Moreover,  the  increase  in  circulating 
levels of FFA enhances skeletal muscle lipid accumulation, and this has been implicated in 
the  induction  of  Obesity‐related  insulin  resistance  [105].  In  fact,  increased  lipid 
accumulation  results  in activation of protein kinase C θ and  the  JNK/SAPK pathway,  in 
part through the elevated production of ceramide, which mediates impaired insulin signal 
transduction in muscle [106, 107]. 
Among  the  various  adipokines  secreted  by  adipose  tissue  influencing  the  insulin 
signaling,  the  most  important  seems  to  be  the  RBP4;  it  induces  insulin  resistance 
interfering with  the  intracellular  insulin  signaling pathway  in muscle,  through  reduced 
PI3K  signaling,  and  enhanced  expression  of  the  gluconeogenic  enzyme 
Phosphoenolpyruvate Carboxykinase  (PEPCK)  in  the  liver  through  a  retinol‐dependent 
mechanism [60]. 
 Another manner in which adipose tissue contributes to the pathophysiology of insulin 
resistance  is  through  the excessive release of proinflammatory cytokines.  In Obesity,  the 
classic features of acute  inflammation tumor, rubor, dolor, calor  (swelling, redness, pain, 
and  fever  are  absent,  but  chronic  inflammation  and  release  of  inflammatory  cytokines, 
including TNFα, IL6 and interleukin‐1β (IL1β), is observed. The source of these cytokines 
in  adipose  tissue  is  debated.  A  report  by  Ferrante  and  colleagues  [98]  suggested  the 
primary role of macrophages infiltration in adipose tissue; adipocyte cell death typical of 
Obesity  is  the  primary  event  underlying  insulin  insensitivity,  because  it  triggers  the 
release of macrophage chemoattractant protein‐1(MCP1) by the adipocyte and recruitment 











act  through  serine/threonine  phosphorylation  of  IRS1,  and  this  process  has  two major 
effects. First, serine/threonine phosphorylated IRS molecules are less able to associate with 
the insulin receptor and downstream target molecules, especially PI3K (Evans et al. 2005), 
resulting  in  impaired  insulin  action  and  Akt/PKB  activation.  Secondly,  the 
serine/threonine  phosphorylated  forms  of  IRS  molecules  are  more  susceptible  to 
proteasome mediated degradation [111]. Inflammatory cytokines work at the same  level. 
TNFα,  through  the  serine‐phosphorylation of  the  IRS1, prevents  its  interaction with  the 
insulin  receptor  β  subunit,  and  stops  the  insulin  signaling pathway  [65].  Subsequently, 
events downstream  of  insulin‐receptor  signaling  are diminished. Moreover, TNF‐α  and 
IL‐6  act  through  classical  receptor‐mediated  processes  to  stimulate  both  the  c‐Jun 




obese patients, which have  a predominant  accumulation of  fat  in  the upper part of  the 
body have also more extensive visceral adipose depots  (VAT), and  this raises  the risk of 
insulin  resistance,  Type  II  Diabetes,  and  further  risk  factors  of  metabolic  and 
cardiovascular  diseases  [112],  given  that  visceral  abdominal  adipocytes  are  more 
endocrinologically  active  than  subcutaneous  adipocytes  [95].  Excess  of  VAT  is 
characterized by anomalies of blood‐glucose homoeostasis, elevated plasma  triglycerides 
and  low  levels of high‐density  lipoprotein  (HDL)  cholesterol. These disorders  are often 




 Two  hypotheses  have  been  proposed  to  explain  the  glucose  intolerance,  insulin 
resistance  and  lipid  abnormalities  associated with  visceral Obesity.  The  first  and  older 
explanation is the “portal hypothesis” advanced by Björntorp [113]. It has been shown that 
VAT releases a  large amount of FFA and hormones/cytokines  in  the portal vein  that are 
then directly delivered to the liver; VAT‐derived FFA alters several liver functions: reduce 
hepatic  glucose  uptake  in  the  postprandial  period,  positive  regulate  gluconeogenesis, 
reduce  insulin  suppression  of  gluconeogenesis,  and  induce  insulin  resistance,  mainly 
through PKC activation. The  second hypothesis  concerns  the delivery of  the adipokines 
involved  in  insulin  sensitivity  (TNFα,  IL6,  interleukin,  leptin,  resistin,  adiponectin) 
released within VAT, into the portal vein. 
Moreover,  also  in  lean  individuals  insulin  resistance  is  strongly  associated  with 
differences in body fat distribution: lean individuals with a more peripheral distribution of 
fat  are  more  insulin  sensitive  than  lean  subjects  who  have  their  fat  distributed 
predominantly centrally [114].  





adiponectin  by  visceral  adipocytes  is  greater  than  that  of  subcutaneous  adipocytes,  the 
subcutaneous  depot  represents  a  greater  proportion  of  total  body  fat,  and  thus  its 
contribution to total adiponectin levels is greater.  
Many  genes  interact with  the  environment  to  produce  insulin  resistance.  The  gene 
variant most commonly associated with  insulin sensitivity  is  the P12A polymorphism  in 
PPARγ, which is associated with an increased risk of developing diabetes [116]. A number 
of genes associated with  β‐cell dysfunction have been  identified,  such as  the hepatocyte 
nuclear  factor‐4α  and  1α  genes,  but  many  other  candidates  (calpain  10,  adiponectin, 
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Reactive  Oxygen  Species  (ROS)  are  a  group  of  highly  reactive molecules  including 
oxygen anions and  radicals, or milder oxidants  such as hydrogen peroxide.  In  the  cells, 
ROS are prevalently generated at the mitochondrial level in a non‐enzymatic way, because 
ROS are normal products of the electron transport chain (ETC), where oxygen is reduced 
to  produce water.  In  few,  but  constant  cases,  a  proximal  and  incomplete  reduction  of 
molecular oxygen occurs, primarily at  two discrete points, namely at complex  I  (NADH 
dehydrogenase)  complex  III  (ubiquinone–cytochrome  c  reductase),  leading  to  the 
formation of the superoxide radical (O2−) [117]. 
Superoxide  anions  can  react  with  nitric  oxide  produces  peroxynitrite,  or  be 
enzymatically  converted by  a manganese  Superoxide Dismutase  (MnSOD)  to hydrogen 
peroxide,  that  together  with  superoxide  anions  and  peroxynitrite  represent  the 
mitochondrial ROS, very powerful  chemical oxidants  (Turrens, 2003). Cytosolic  enzyme 
systems  also  contribute  to  oxidative  stress,  among  others,  the  plasma 
membrane/phagosome  associated  enzyme  complex,  termed  NADPH  oxidase,  a 
superoxide‐generating system  that was  first described  in phagocytic cells of  the  immune 
systems, as macrophages and neutrophils, which uses the superoxides to damage and kill 
pathogenic  organisms. However,  it  has  now  become  clear  that NADPH  oxidase  is  not 
restricted to the immune system but alternative isoforms may be active in many other cell 
types as an essential component of redox signaling mechanisms. 
Cells  arrange  antioxidant  systems  to  neutralize  ROS,  to  prevent  their  accumulation 
inside  the cell and  thus  the so‐called oxidative damage, and  they are represented by  the 
enzymatic scavengers SOD, Catalase and Glutathione (GSH) Peroxidase. In mitochondria, 





peroxide  to  molecular  oxygen  and  water,  and  is  found  exclusively  in  peroxisomes 
(Turrens,  2003).  Mutations  in  genes  involved  in  the  cellular  scavenging  system  are 
associated with  neurological  diseases,  such  as  the  Parkinson’s  disease  (mutation  in  the 
mitochondrial targeting sequence (MTS) of MnSOD gene) [118], and Amyotrophic lateral 
sclerosis  (ALS)  (mutation  in  the gene coding  for  the Copper Zinc Superoxide Dismutase 
(CuZnSOD),  the  cytosolic  isoform  of  the  scavenging  enzyme)  [119].  Moreover,  non‐
enzymatic molecules  are  involved  in  scavenging  ROS:  ascorbate,  pyruvate,  flavonoids, 
carotenoids and  the vitamin E,  located  in  inner mitochondrial membrane,  is a powerful 
antioxidant which accepts unpaired electrons to produce a stable product.  
Although  the  cellular defense mechanisms,  it  is  still possible  for ROS  to  accumulate 






enzymes  to  correct  damage  to DNA  or mutations  induced  by  oxidants  [117,  121],  but 
mitochondrial DNA  is generally more sensitive  then nuclear DNA  to oxidative damage, 
probably because of its limited DNA repair system, or its proximity to the main source of 




















In  addition  to  these  effects,  a  rise  in  ROS  levels may  constitute  a  stress  signal  that 
activates  specific  redox‐sensitive  signaling pathways  (summarized  in  figure 5). This will 
lead to cell dysfunction and possibly death resulting in oxidative stress‐related diseases. 
Apoptosis (or programmed cell death) is the mechanism used by mammals, plants and 
other organisms  to eliminate redundant or damaged cells  [123], and can be  triggered by 




where  it  joins another  factor  (Apaf‐1), and  this  in  turn activates  the death program. As 
cytochrome  c  is  an O2  scavenger  and  at  its  release  the  respiratory  chain  becomes more 
reduced because electron  flow between Complex  III and Complex  IV slows down  [124], 




Furthermore,  the  continuous  formation  of  ROS  in  mitochondria  and  the  slow 
accumulation  of  DNA  damages,  results  in  the  aging  process  [125].  Thus,  factors  that 
increase  resistance  to  stress  should  have  anti‐ageing  benefits  and  lead  to  enhanced  life 
span. Many mutations  have  revealed  links  between  longevity  and  stress  resistance  in 
multicellular  organisms:  loss‐of‐function  mutations  of  the  age‐1  (the  human  PI3K 
homologue) gene in C. elegans is associated with a 65% increase in lifespan [126], while in 
Drosophila, mutations  in  the methuselah  (mth) gene not only enhances  longevity but also 
increases resistance to heat stress and intracellular ROS [127]. 
Another  study  found an unexpected  correlation between  life  span and  control of  the 
oxidative stress response: targeted mutation of the shc gene  locus, which caused ablation 
of a  splice variant of 66 kDa  (p66shc),  resulted  in  selective  resistance  to oxidative  stress 
and extended (+30%) life span in mice [128]. p66shc is one of three splice variants derived 
from  the  shc  locus:  p52shc  and  p46shc  are  important  adaptor  proteins  regulated  by 
tyrosine  phosphorylation  and  participating  in  growth‐factor‐  and  stress‐induced  ERK 
activation.  p66shc  also  undergoes  tyrosine  phosphorylation  in  response  to  extracellular 
signals, however  the p66shc  is unique  in  that  it also becomes phosphorylated on  serine 
residues in response to certain extracellular signals and, in the case of oxidative stress, this 
leads to apoptosis. Serine phosphorylation of p66shc is also stimulated by insulin [129]. 














complications of diabetes,  including nephropathy,  retinopathy, neuropathy,  and macro‐ 




concept  reviewed  by  Brownlee:  hyperglycemia  causes  diabetic  complications  through 
increased  polyol  pathway  flux,  increased  advanced  glycation  end‐product  (AGE) 
formation,  activation  of  protein  kinase  C  (PKC)  isoforms  and  increased  hexosamine 
pathway  flux,  and  the  four  different  pathogenic  mechanisms  reflects  a  single 












Figure  6  Hyperglycemia  activates  four  intracellular  pathways  through  mitochondrial  superoxide 
overproduction.  Excess  superoxide  partially  inhibits  the  glycolytic  enzyme  GAPDH,  thereby  diverting 
upstream metabolites from glycolysis into pathways of glucose overutilization. This results in increased flux 
of  dihydroxyacetone  phosphate  (DHAP)  to  DAG,  an  activator  of  PKC,  and  of  triose  phosphates  to 
methylglyoxal,  the main  intracellular AGE  precursor.  Increased  flux  of  fructose‐6‐phosphate  to UDP‐N‐




Moreover,  increased FFA metabolism may also  lead  to  increased ROS production.  It has 
been  reported  that glucose or FFA  initiate  the  formation of ROS  in muscle,  adipocytes, 




the  β‐cell,  since many  studies  have  suggested  that  β  cell  dysfunction  is  the  result  of 
prolonged  exposure  to  high  glucose,  elevated  FFA  levels,  or  a  combination  of  the  two 
[135]. 
As previously discussed,  insulin  resistance plays a central  role  in  the development of 
several  metabolic  disorders  and  diseases,  such  as  Obesity,  Type  II  Diabetes  and  the 
Metabolic Syndrome. Oxidative  stress has been postulated  to play  an  important  role  in 
diminishing  insulin  sensitivity  [136],  and  actually  the  cellular  effectors  linking  the 
oxidative damage  to  the onset of an  insulin resistant state are object of  intense research. 
The  oxidative  stress‐induced  insulin  resistance  hypothesis  was  finally  confirmed  in  a 
paper  by  Bloch‐Damti  et  al.,  [137]:  the  authors  found  that  oxidative  stress  condition 
(treatment with H2O2)  caused  an  impairment  of  the  intracellular  insulin  pathway,  thus 
leading  to  insulin  resistance  in 3T3‐L1 adipocytes. At  this  level,  insulin  resistance  could 
represent a defensive system of the cell: as it inhibits any insulin action, should result in a 
decreased  cellular  ROS  production.  Fridlyand  et  al.  suggest  that,  because  of  cellular 
incapacity to modify glucose, FFA or insulin concentrations in the blood, the restriction of 
glucose  entry  prevents  ROS  overproduction,  as  to  say  insulin  resistance  could  be  a 
physiological  mechanism  of  prevention  of  oxidative  stress,  activated  by  the  cell  in 
response to conditions stimulating ROS production [138]. 
Thus, concomitant with the failure of antioxidant defense, ROS contribute to the onset of 
Type  II Diabetes and  its complications  [134], acting not only  through  the  induction of a 
macromolecular damage, involving oxidation of DNA, lipid and protein; in addition, ROS 
can  work  as  signaling  molecules,  activating  cellular  stress‐sensitive  kinases.  In  fact, 
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exposure  of  different  cell  lines  to  hydrogen  peroxide  leads  to  the  activation  of  stress 
kinases, such as c‐JunN‐terminal kinase, p38‐MAPK, IκB kinase, and extracellular receptor 
kinase  1/2,  and  this  activation  determines  insulin  resistance  achieved  through  the 
serine/threonine  phosphorylation  of  IRS1  [137].  Additional  oxidative  stress‐sensitive 
kinases  are  reported  to  be  involved  in  IRS‐mediated  insulin  resistance  and  include  the 
mammalian target of rapamycin (mTOR) [139], several isozymes of PKC, including PKCβ 
and PKCε  [140,  141],  and  the  IKKβ–NFκB  signaling  cascades  [142],  and  acting  through 
phosphorylation of the insulin receptor or IRS proteins. 
Looking  for  cellular  intermediates  between  oxidative  stress  and  insulin  resistance, 
evidence  for  ceramide as a  candidate  linking nutrient  excess  to  the  induction of  insulin 
resistance in rodents has recently been published [143]. In addition, diet‐induced Obesity 
in mice  increases  the  expression  of  inducible  nitric  oxide  synthase  (iNOS)  in  skeletal 















as  signaling  molecules  to  activate  several  stress  sensitive  pathways  in  Type  II  Diabetes  development. 
Activation  of  these  pathways,  such  as NF‐kB,  p38 MAPK,  JNK/SAPK,  and  hexosamine,  leads  to  both 







Protein kinase C  (PKC) are a  family of  serine/threonine‐specific kinases  implicated  in 
intracellular  signal  transduction  of  many  key  cellular  events,  as  cell  proliferation, 
apoptosis,  smooth  muscle  contraction,  and  secretion  [146],  and  also  involved  in  the 
pathogenesis  of Obesity  and  insulin  resistance  [147].  PKC  consists  of  several  isoforms 
subdivided  into  three  classes:  (1)  the  classical  or  conventional  PKCs  (α,  βI,  βII  and  γ) 
activated by Ca2+ and DAG; (2) the new or novel PKCs (δ, ε, η and θ) activated by DAG but 
Ca2+ independent; and (3) the atypical PKCs (λ and ζ), which are Ca2+ and DAG insensitive 
[148]. Although most  cells  express more  than  one  type  of  PKC,  differences  among  the 




now well  established  that,  in  diabetic  animals,  hyperglycemia  increases  the  amount  of 
DAG  in many  tissues exposed  to Type  II Diabetes complications, as microvascular cells, 
retina and renal glomeruli. Hyperglycemia achieves this primarily by increasing de novo 
DAG synthesis, and this, in turn, increases activates PKC (primarily β and δ isoforms) both 
in  cultured  vascular  cells  [150]  and  in  retina  and  glomeruli  of  diabetic  animals  [151]. 
Activation of PKC in cells exposed to hyperglycemia can be achieved through alternative 
routes,  including  intermediates  from  metabolic  pathways,  the  AGE‐RAGE  (advanced 
glycation end products and their receptors) pathway activation and oxidative stress (figure 
8). Moreover, Type II Diabetes is often associated with derangement of metabolism such as 
dyslipidemia.  Increased  circulating FFA  in Type  II Diabetes has been  shown  to activate 
PKC  in  vascular  cells  [152]. Altered  polyol  and  hexosamine  pathways  are  involved  in 


















Figure  8  Involvement  of  PKCs  in  the  development  of  diabetic  complications.  High  glucose  levels 







Evidences,  especially  from  knock‐out  studies,  have  indicated  that  several  of  PKC 
isoforms  can  modulate  glucose  or  energy  metabolism  in  an  isoform‐specific  manner: 
inactivation of PKCλ  increased whole‐body  insulin  sensitivity, diminishing  triglycerides 
content  selectively  in  liver,  without  affecting  their  level  in  muscle  [156].  Whereas 
inactivation of PKCα unaffected either basal glucose or energy metabolism [157], atypical 
PKC  isoforms  are  required  for  insulin‐stimulated  glucose  uptake  in  muscle  and 
adipocytes, and defects in atypical PKC in human muscle are found in insulin resistance, 
Obesity and Type II Diabetes. In muscle, these defects are due to both impaired activation 
of PI3K and  the direct activation of atypical PKCs by  the  lipid product of PI3K, PI‐3,4,5‐
(PO4)3  [158]. Moreover,  inactivation  of  PKCθ  represents  a  risk  factor  for  the  onset  of 
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Obesity  and  enhances  dietary‐induced  insulin  resistance  [159].  Unlike  many  PKC 
isoforms, PKCβ  is expressed as a major  isoform  in a variety of  tissues, and knock out of 
PKCβ  caused  slight  changes  in  glucose  homeostasis  [160];  moreover,  PKCβ  has  been 
linked with many vascular abnormalities in retinal, renal, and cardiovascular tissues [161]. 




All  these  evidences  highlight  the main  role  of  PKC  in  the  development  of  insulin 
resistance  and  Type  II  Diabetes  as well  as  their  involvement  in  the  onset  of  diabetic 
complications,  but  the  role  of  the  isoform  β  has  to  be  stressed.  PKCs  are  activated  in 
conditions  of  oxidative  stress  [162]  and  PKCβ  is  not  an  exception  [163];  furthermore 
Metformin,  a widely used  antidiabetic  agent,  inhibits  the  glucose‐induced  activation  of 
PKCβ  through  an  antioxidant mechanism  [164]. Recently, Liberman  et  al. demonstrated 
PKCβ implication in the rearrangements of insulin intracellular signal transduction. They 
found  remarkably  elevated  expression  level  and  activation  state  of  PKCβII  in  the  fat 
tissues of diabetic ob/ob mice and  in high‐fat diet‐fed mice compared with that from  lean 
animals, and  these  increases were associated with enhanced phosphorylation of  IRS‐1 at 
Ser336/332, an  important negative modulator of  insulin signaling  [165]. Furthermore, PKCβ 
inhibitor has shown beneficial effects in diabetic complications as diabetic retinopathy and 

















Diabetes,  adipose  tissue  has  been  revaluated  as  an  active  and  important  organ  in 






they may  substitute bone‐marrow derived  stem  cells  in  their promising applications  for 
tissue  repair  and  regeneration.  Indeed,  subcutaneous  adipose depots  are  accessible  and 
abundant, thereby providing a potential adult stem cell reservoir for each individual. 
Further  complexity  is  added  by  the  observation  that  intramuscular  fat  stores  and 
substitution of muscle with adipose  tissue have been reported  to strongly correlate with 
insulin  resistance and  thus  to  the development of Type  II Diabetes and other metabolic 
disorders. A key biological issue is how intra/intermuscular adipose tissue originates and 
proliferates and attention has been recently focused on the transdifferentiation of muscle 
progenitors  to  the  adipogenic  lineage,  given  that  myopathic  skeletal  muscle  is 




possible  inductor of  adipose differentiation of mesenchymal  stem  cells  residing  in both 














Adipose‐derived  Stem  Cells  (ADSCs)  were  isolated  from  human  lipoaspirates  using 
standard  protocols  and  their  in  vitro  differentiation  capacity  into  various mesenchymal 
tissues was  first established. To maximize nutrients delivery and  to mimic  the dynamic 
stress conditions stimulating  formation of extracellular matrix, ADSCs were seeded onto 
hyaluronan  based  sponge  in  a  perfusion  system,  called  Bioreactor,  which  allows  the 













Three  classical  differentiation  protocols  into  osteoblasts,  chondrocytes  and  adipocytes 
(described  in  Materials  and  Methods)  were  tested  to  characterize  the  ADSCs 
differentiation  capacity,  and  the  results  were  verified  by  morphological  analyses 
(histological and electron microscopy analyses) and molecular approaches. 
Osteogenic  differentiation  was  detected  fixing  and  staining  the  cultured  cells  for 
alkaline  phosphatase  activity  (fig.1  Osteogenic Medium  A).  The  histochemical  reactions 
turned  out  markedly  positive  (blue  cells),  whereas  chondrocyte  markers 




large  amount  of  granular  endoplasmic  reticulum  and  completely  surrounded  by  fully 
mineralized bone matrix. More, these results well matched the molecular analysis by real‐
time PCR (RT‐PCR, fig.1 Osteogenic Medium C), carried out in parallel batches of cells, that 
revealed  expression  of  bone  differentiation  markers,  such  as  alkaline  phosphatase, 
collagen  type  I,  osteopontin,  osteonectin  and  osteocalcin,  and  negativity  for  adipocyte 
markers  (fatty  acid  binding  protein  4  (FABP4),  peroxisome  proliferators  activated 
receptor–gamma  (PPARγ),  lipoprotein  lipase  (LPL), glucose  transporter  4  (GLUT4)) and 
chondrocyte markers (type II collagen). 
Chondrogenic  differentiation  was  confirmed  by  positive  cell‐staining  at  the 
immunocytochemistry  for  type  II  collagen  (fig.1  Chondrogenic  Medium  A),  while 
completely  negative  for  alkaline  phosphatase  and  lipid  staining.  Transmission  electron 
microscopy (TEM) showed (fig.1 Chondrogenic Medium B) that the cells contained a certain 
number of well preserved mitochondria, an  expanded  cytoplasm  rich  in  free  ribosomes 
and  abundant  rough  endoplasmic  reticulum,  a well  developed Golgi  apparatus  and  a 
relevant number of glycogen granules. Cell membranes showed contact points and finger‐
like protrusions; microfibrils were present in the intercellular spaces, frequently connected 
to  cell  membranes  from  which  they  looked  extruded.  The  RT‐PCR  results  confirmed 
46 
 
chondrogenic  differentiation,  by  revealing  expression  of  type  II  collagen  and  total 
negativity for osteogenic and adipose marker (fig.1 Chondrogenic Medium C). 
Finally, Adipogenic  differentiation was  detected  by  cell  staining with  the  triglycerides‐
specific marker Oil Red O. Oil Red O  staining  of  the  cells  revealed  loading with  lipid 
droplets (fig.1 Adipogenic Medium A), and negativity for alkaline phosphatase and type II 
collagen.  The  EM  pictures  (fig.1  Adipogenic Medium  B)  showed  the  typical  features  of 
adipocytes (presence of lipid droplets), and RT‐PCR (fig.1 Adipogenic Medium C) revealed 
the  expression  of  adipocyte markers,  such  as  FABP4, PPARγ, LPL  and GLUT4.  Similar 
data have been obtained by us and others using ADSC from mouse or rats, or using more 
standard culture conditions [171].  
These  results  indicate  that,  upon  application  of  suitable  differentiation  protocols, 






















































Adipose‐derived Stem Cells (ADSCs) cultured on Hyaff ®11 sponges in Osteogenic, Chondrogenic
or Adipogenic Medium
A Histochemical reaction [Osteogenic Medium: alkaline phosphatase activity (blue
cells)][Chondrogenic Medium: Type II Collagen positivity (blue cells)][Adipogenic Medium: Oil
Red O Staining (red cells)] Magnification: 20X. B: Transmission electron microscopy (TEM)
showing lineage‐specific phenotypes. Magnification: 6500X. C: mRNA expression of adipogenic,
chondrogenic and osteogenic markers analyzed after 14 days by semi‐quantitative real time PCR.
Results for each condition are from quadruplicate experiments and values are expressed in relative







unknown.  In  this  work  is  investigated  the  potential  of  high  glucose  concentration,  a 
condition  leading  to  an  increase  in  adipose  tissue  in  vivo  [172]  to  affect human ADSCs 
differentiation into mature adipocytes in vitro (fig. 2). ADSCs were maintained for 14 days 
in a  low glucose medium  (LG‐DMEM,  i.e. DMEM  supplemented with 10% FBS and 5.5 
mM glucose) or  in a high glucose medium  (HG‐DMEM,  i.e. DMEM supplemented with 
10% FBS and 25 mM glucose), and  then analyzed by morphological  (histochemistry and 
electron  microscopy)  and  molecular  approaches.  Staining  with  Oil  Red  O  (fig.  2  A), 
selective for triglyceride depots, clearly revealed substantial adipose differentiation in cells 
grown  in HG‐DMEM (ii) compared to cells grown  in  lower glucose (ii), result confirmed 
also  by  Oil  Red  O  staining  quantification  (HG‐DMEM:  4.18±0.21  OD  and  LG‐DMEM: 
2.16±0.11 OD  at  520  nm). Accordingly,  EM  analysis  (fig.  2  B)  showed  numerous  cells 
containing  large  lipid  droplets  surrounded  by  a  thin  ring  of  cytoplasm,  indicating  the 
typical  adipose  phenotype,  and  SEM  microscopy  (fig.  2  C)  showed  a  population  of 
rounded  cells  of  various  sizes,  i.e.  the  typical  appearance  of  adipose  tissue.  The  lower 
magnification  (fig.  2 Ci)  reveals  the presence  of  round  adipocytes  on  both  sides  of  the 
specimen.  
In  high  glucose  conditions,  RT‐PCR  analysis  of  mRNA  transcripts  (fig.  2  D) 
revealed  significant  expression  of  adipocyte‐specific  proteins,  such  as  PPARγ,  LPL, 
adiponectin,  GLUT4  and  sterol  regulatory  element‐binding  protein  1c  (SREBP1c). 


























* * * *
Results fig. 2
Adipose‐derived Stem Cells (ADSCs) cultured on Hyaff ®11 sponges in LG and HG‐DMEM
A: Oil Red O staining of ADSCs grown in LG (i) or HG‐DMEM (ii). Lipid droplets are in red,
biomaterial fibers in blue Magnification: 20X B: Transmission electron microscopy (TEM) of two
0
. .
representative fields. Magnification: 6500X. C: Scanning Electron microscopy (SEM) of ADSCs at
two different magnifications. D: mRNA expression of adipogenic, chondrogenic and osteogenic
markers analyzed after 14 days by semi‐quantitative real time PCR in ADSCs cultured on 3D
scaffolds in LG and HG DMEM. Results for each condition are from quadruplicate










default differentiation  route of adipocyte precursors. To  investigate whether  it  reflected 
conversely  the  differentiation  of  uncommitted  mesenchymal  precursors  or  even  the 
transdifferentiation of  stem  cells of other mesenchymal  tissues,  the analysis was  turned 
out to primary cultures of skeletal muscle. These cells can be easily obtained from animal 
models  and  thus  the  following  experiments  were  carried  out  on  cells  derived  from 
neonatal  rats.  Muscle‐derived  Stem  Cells  (MDSCs)  from  mouse  or  rats  can  be 
differentiated  into  large  myotubes,  carrying  most  phenotypic  properties  of  skeletal 






culture  for 18‐25 days before analysis.  In LG‐DMEM, as  revealed by either counting  the 
cells with large vacuoles in the cytoplasm (fig. 3 Ai) or those positive for the lipid specific 
dye Bodipy (fig. 3 Aii) the percentage of cells with a morphological adipocyte phenotype 
was  only  3.3  ±  2.4%.  In  HG‐DMEM,  a  highly  significant  increase  in  adipocyte 





* To  rule out  that  the process  represents only  the differentiation of a contaminating cellular 
population  of  adipocyte  precursors,  control  experiments were  done.  Separate  cultures  were 
prepared  from  upper  and  lower  limb  muscles  (the  former  may  be  partly  contaminated  by 
subcutaneous  and  visceral  adipose  tissue, while  the  latter  is  virtually  devoid  of  it)  and  the 
efficiency  of  high  glucose  induced  adipocyte  differentiation  was  very  similar  (upper  limbs: 
8.9±2.7%; lower 10.3±1.8%). 
Then  the  adipose  differentiation  efficiency  in  the  three‐dimensional  scaffold  of  the 
bioreactor was verified. MDSCs were thus seeded onto the hyaluronan based sponge and 
maintained  in  culture  for  14  days  under  LG‐DMEM  or  HG‐DMEM  perfusion.  Then, 
histochemical and ultrastructural analyses of  the cell culture were carried out. As  to  the 




staining  (fig.  3 Di);  quantification  of Oil  Red O‐stained  cells  showed  a marked  higher 





with  an  adipocyte  phenotype  obtained with HG‐DMEM  from muscle  cultures  did  not 
differ significantly from that observed under the same conditions using ADSCs (3.87±0.31 
OD  at  520nm  in MDSCs  and  4.18±0.21  OD  at  520nm  for  ADSCs),  indicating  that  the 



































High glucose induces adipocyte differentiation of Muscle‐Derived Stem Cells (MDSCs)
A and B: Phase contrast image (i) and Bodipy‐staining (ii) of MDSCs cultured in LG‐DMEM (A)
or HG‐DMEM (B). C and D: Oil Red O staining (i) and SEM analysis (ii) of MDSCs cultured for
14 days on Hyaff ®11 sponges in LG‐DMEM (C) and HG‐DMEM (D). Lipid droplets are in red,
nuclei in blue (40X). E and F: Adipogenic, chondrogenic and osteogenic markers mRNA expression
analyzed by semi‐quantitative real time PCR in MDSCs cultured on 3D scaffolds days in LG and
HG DMEM for 7 (E) and 14 (F) days. Results for each condition are from quadruplicate











about  their development  are  given:  increased polyol pathway  flux;  increased  advanced 
glycation  end‐product  (AGE)  formation;  activation  of protein  kinase C  (PKC)  isoforms; 
and  increased  hexosamine  pathway  flux.  The  unifying  mechanism  linking  these 
hypotheses  proposed  by  Brownlee  [134]  is  the  induction  of  oxidative  stress  by  high 
glucose  through  three  mechanisms,  NADP(H)  oxidase,  xanthine  oxidase  and  the 
mitochondrial respiratory chain. 
PKC  isoforms, PKCβ and δ  in particular, have been  shown  to be activated by oxidizing 
conditions  [163] and  in  this work was verified whether  these mechanisms  represent  the 
signalling route in stem cells differentiation to adipocytes.  
First, ROS production enhancement during high glucose incubation was verified. MDSCs 
were  obtained  as  in  fig.  3,  but  the  cells were  seeded  onto  24 mm  glass  coverslip  for 






This  condition  is known  to  activate PKCβ,  as previously  observed  in  endothelial 











i) the  role of ROS  in adipocyte differentiation was verified adding H2O2  (in vitro model of 
oxidative stress) to LG‐DMEM; the enhancement of the differentiation rate raised to 









iii) then,  transduction  of  the  cells  in  HG‐DMEM  with  a  PKCβ‐expression  vector 
triggers  a  major  enhancement  of  lipid‐loaded  cells  (28.7±6.9%,  ∼+300%),  while 
infection with a control viral vector  (an adenoviral vector expressing mtGFP) and 
PKCβ  if  added  to  cells  in  LG‐DMEM  did  not  increase  adipocyte  differentiation 
(control experiment non presented). 
The  same  results were  obtained  seeding MDSCs  onto  hyaluronan  base  sponge  of  the 
bioreactor (fig. 5 B): the enhancement of differentiation observed in cells treated with H2O2 





*As  a  control,  an  unrelated  gene  was  silenced  (FHIT),  since  a  siRNA  scrambled 











































































ROS production of MDSCs cultured in LG and HG‐DMEM and glucose induced PKCβ‐activation
A: 7 days after seeding, cells were loaded with the CM‐H2‐DCFDA and analysed by confocal
microscopy. Basal ROS production is expressed as mean of CM‐DCF oxidation rate (F.a.u./s).
Representative traces of CM‐DCF oxidation kinetics are shown on the right ( LG‐DMEM and o
HG‐DMEM). B: PKCβ membrane translocation, as revealed by immunofluorescence microscopy.
Representative images show cells maintained in LG‐DMEM (i), incubated for 1h in HG‐DMEM (ii)
and treated with PMA, 500nM (iii). The graphs show the quantitation of PKCβ fluorescence



































Quantitation of MDSCs adipocyte differentiation in different conditions
A: MDSCs cultured in different conditions: HG‐DMEM, LG‐DMEM, LG‐DMEM supplemented
with 100μM H O PKCβ‐overexpression in HG‐DMEM and PKCβ siRNA in HG‐DMEM The2 2, .
efficiency of MDSCs differentiation was quantitated by counting the percentage of Bodipy loaded
cell. The histogram shows the percentage of differentiation ± SEM. B: MDSCs cultured on Hyaff®11
sponges in LG‐DMEM supplemented with 100μM H2O2 (i), PKCβ‐overexpression in HG‐DMEM
(ii) and PKCβ siRNA in HG‐DMEM. Adipogenic differentiation was confirmed by Oil Red O






The  ability  of  in  vitro  differentiated  adipocytes  to  generate  mature  and  viable 
adipose tissue in vivo was tested. ADSCs seeded on HYAFF® sponges and cultured in the 
bioreactor  for 7 days  in high glucose, were  implanted  in  the abdominal area of 8  female 
nude rats (Materials & Methods section). 1, 2, 3 and 4 weeks after insertion of the graft, the 
rats were sacrificed and the grafts analyzed macroscopically (colour, ingrowth and vessels 
formation,  weight,  thickness)  and  microscopically  (pore  size,  specific  and  unspecific 
cellularity, vascularity). The implant appeared well integrated in the subcutaneous tissue 
and not surrounded by fibrotic tissue (fig. 6 Ai at 2 weeks and fig. 6 B at 3 weeks; white 
arrows).  In  addition,  numerous  capillaries  (fig.  6  Ai  and  Bi;  blue  arrows)  revealed 
significant  vascularization  of  the  engineered,  re‐implanted  tissue.  Harvesting  of  the 
sample confirmed that the sponge maintains its volume and soft consistence, and is easily 
dissected from the surrounding tissue (fig. 6 Aii). 
Morphological  characterisation  of  the  explants  confirmed  a major  distribution  of 
preadipocytes over the whole cross‐section (fig 6 Ci (10X), 6Cii (40X)). Significant adipose 
tissue  formation was detected  (black  arrows)  (fig.  6C  i,  ii)  already  at  3 weeks.  In most 
cases,  the  cells  exhibited  the  hallmarks  of mature  adipocytes,  i.e.  a  large  lipid  droplet 
surrounded  by  a  thin  ring  of  cytoplasm,  with  a  flattened  nucleus  located  at  the  cell 
















Macro and microscopic analyses of in vitro differentiated adipocytes implanted in vivo
A, B: Macroscopic aspect 2 (A) and 3 (B) weeks after implantation of the HYAFF®11 sponge seeded
with adipocytes in HG‐DMEM Ai and Bi: images of the implanted tissue in situ; Aii, image of the.
graft after dissection and Bii, low magnification images of the 4 implanted grafts.
C, D: Histological analyses of the grafts 3 weeks after implantation in diverse magnifications(C 20X
andD 40X) by haematoxilin/eosin staining of newly formed tissues.






Due  to  its primary  role  in  the development  of Obesity  and  type  II Diabetes,  the 
major interest on adipose tissue resides in the identity of the adipocyte precursor cell and 
regulation  of  the  differentiation  process.  Since  the  molecular  actors  involved  and  the 
whole adipogenic transcriptional pathway is now fully elucidated, the signals occurring in 
pathological  conditions  and  in  aging  are  still  incompletely  understood.  It  is  now well 
established  that  the  increase  of  adipose  tissue  volume derives  from differentiation  of  a 
pool of adipose precursors present  in  the  tissue, called pre‐adipocytes, committed  to  the 
adipogenic lineage and ready to receive the appropriate differentiation signal. Moreover, 
in the adipose tissue is present a reservoir of stem cells which, upon differentiation signals, 
allows  tissue  regeneration and  increase  in  fat cells number. Thus, Adipose‐derived stem 
cells  (ADSCs)  represent  the  key  cellular  element  for  the  control  of  body  adiposity  and 
furthermore, depending on the stimulating signals they receive, can differentiate not only 
in adipocyte, but also in other mesenchymal cells, such as chondrocytes or osteocytes, and 
in endothelial and neuronal cells. Thus,  they may  substitute bone‐marrow derived  stem 




in muscle  fibres. Muscle‐derived  stem  cells  (MDSCs)  include  the  so‐called  satellite  cells, 
the precursor cells capable of differentiating in vivo to mature muscle fibres and in vitro up 





of adipocytes  in appropriate culture conditions (adipogenic medium)  in a process that  is 
enhanced  by  the  insulin  sensitizer  rosiglitazone  [176]. Moreover,  activators  of  PPAR‐γ 
cause  in  muscle  the  induction  of  genes  involved  in  fatty  acid  uptake,  storage,  and 
metabolism [177] and that the myogenic cell line C2C12 can be converted to adipocytes by 
overexpression of PPAR‐γ and C/EBP [178].  
Intramuscular  fat  accumulation  and  substitution  of muscle with  adipose  tissue  have 
been reported to strongly correlate with  insulin resistance and subsequently with type II 
Diabetes  development  [179].  For  this  reason,  how  intra/intermuscular  adipose  tissue 
originates and proliferates in Diabetes and in other metabolic or myodystrophic conditions 
is  still  a  matter  of  debate.  Attention  has  been  recently  focused  also  on  the 
transdifferentiation of muscle progenitors to the adipogenic lineage, given that myopathic 
skeletal muscle is characterized by the replacement of myofibers by adipose tissue [180].  
One of  the major  features of  type  II Diabetes, hyperglycemia,  triggers many  changes  in 
both  gene  expression  and  protein  function,  contributing  to  the  development  of 
complications  of  Diabetes  itself  [134].  Furthermore,  recently  was  discovered  that 
hyperglycemia is able to induce de novo lipogenesis and intracellular lipid accumulation 




concentration  induced  full adipogenic  conversion of  stem  cells  residing  in both adipose 
and muscle tissue and a clear induction of adipogenic transformation was observed upon 
the application of high glucose  culture  conditions. This differentiation potential of high 






morphological  and molecular  criteria  and  also  by  the  capacity  of  these  cultured  cell  to 
form  viable  and  vascularized  adipose  depots when  implanted  in  vivo.  Stem  cells  from 
muscle  tissue,  when  cultured  in  high  glucose  conditions,  form  viable  and  functional 
adipocytes  in  the  same  proportion  as  the  same  cells  from  the  adipose  tissue,  since  the 
percentage of high glucose‐differentiated adipocytes from muscle tissue is very similar to 
that obtained from adipose‐derived cells. Moreover, to rule out that the process represents 
only  the differentiation  of  a  contaminating  cellular population  of  adipocyte precursors, 
control experiments were done. Separate  cultures were prepared  from upper and  lower 
limb  muscles  (the  former  may  be  partly  contaminated  by  subcutaneous  and  visceral 
adipose tissue, while the latter is virtually devoid of it) and the efficiency of high glucose 
induced adipocytic differentiation was very similar. Taken together, this findings indicate 
that  the process observed  is  the  same  from both  cell  types,  and  represents  the genuine 
differentiation  of  uncommitted  mesenchimal  precursors  or  a  trans‐differentiation  of 
myogenic precursors.  In  this process, an  important  role  is attributed  to  reactive oxygen 























The  identification  of  a  primary  role  of  high  glucose  exposure  in  adipocyte 
differentiation  has  some  major  important  conceptual  implications.  It  shows  that  high 
glucose  per  se  has  an  adipogenic  potential,  thus  opening  the  search  for  novel  signal 
transduction pathways operating in Obesity and Type II Diabetes. Secondly, it highlights 
the role of high glucose levels in committing stem cells specifically to the adipose lineage, 
since  incubation  in  high  glucose  lowers  the  expression  of  markers  of  the  other 




reduced  activity  of  stimulatory  factors  [184],  with  consequent  loss  of  muscle  mass. 
However  these  alterations  do  not  account  for  other  features  of  aged  muscle,  and  in 
particular  for  the  increased  lipid content  [185]. The concept  that high glucose  triggers  in 




a  crucial  role  for  Reactive  Oxygen  Species  (ROS).  Interestingly,  among  the  cellular 
consequences of high glucose, increased production of ROS is recognized as a major cause 
of  the  clinical  complications  associated  with  type  II  Diabetes  and  Obesity  (Brownlee). 
Various mechanisms appear to synergize in increasing ROS production, ranging from the 














revealed  by  the  strong  inhibitory  effect  of  siRNA  and  by  the  strong  synergism  of high 




[164] and  reinforces an  important  role  for PKCs  in  the pathogenesis of Type  II Diabetes 
and in adipocyte differentiation, expecially in regards to isoform β. The isoform seems to 




high  glucose  conditions  and  sustaining  the  ROS‐mediated  signalling  route.  This  result 
well agrees with a number of previous observations,  that besides  the  important  role  for 
PKC in Diabetes and in Obesity, highlights a link between PKCs, ROS production and cell 
degeneration  [189].  In  addition  to  the metabolic  effects, PKCs  appear  to be  involved  in 
detecting  and  decoding  a  variety  of  stress  conditions,  including  oxidative  challenges. 
Recently our group  showed  that PKCβ  recruits  the 66kDa pro‐apoptotic  isoform of Shc 
(p66Shc)  to  act  as  oxidoreductase within mitochondria  [190]  and  in  triggering  a  feed‐
forward cycle of ROS production eventually  leading  to cell death  [163]. The same actors 
(PKCs, ROS and eventually p66Shc) may come together in a radically different context, the 
insulin  target  tissues,  where  they  regulate  the  production  of  cellular  signals  linking 
hyperglycemia and the trans‐differentiation of stem cells. How the same signalling route 



















first preplating  (15min or 2 hours), and  in  the replating of non‐rapidly adherent cells. In 





Adipose‐derived Stem Cells  (ADSCs) were extracted  from human adipose  tissues of five 
healthy  female  patients  undergoing  cosmetic  surgery  procedures,  following  guidelines 
from Clinic of Plastic Surgery, University of Padova. Adipose tissues were digested with 
0.075%  collagenase  (type  1A,  Sigma  Chemicals,  St.Louis,  MO)  in  Krebs‐Ringer  Buffer 
(modified KRB:  125mM NaCl,  5mM KCl,  1mM Na3PO4,  1mM MgSO4,  5.5mM glucose, 
20mM HEPES, pH 7.4, 37°C)  for 60 min at 37°C  followed by 10 min with 0.25%  trypsin. 
Floating  adipocytes were  discarded  and  cells  from  the  stromal‐vascular  fraction were 






Sponges  made  of  HYAFF®11,  a  linear  derivative  of  hyaluronic  acid,  in  which  the 
carboxylic function of the monomer glucuronic acid in the hyaluronic acid chain is totally 













- for  the  chondrogenic  phenotype:  50 μg/ml  L‐ascorbic  acid  [Sigma],  1  ng/ml 
transforming  growth  factor‐β1  (TGF‐β1)  [Calbiochem,  CA],  1  ng/ml  of  insulin 
[Sigma],  1  ng/ml  epidermal  growth  factor  (EGF),  [Sigma]  and  10  ng/ml  basic 
fibroblast growth factor (EGF) [Sigma]; 
- finally,  for  adipogenic  phenotype:  1 μm  dexamethasone  (Sigma),  0.1 mm 







To  quantitate  adipocyte  differentiation,  Petri  dish‐cultured  cells  at  18th‐25th  day were 
loaded  for  10 minutes with  40μM  Bodipy  493/503  (4,4‐difluoro‐1,3,5,7,8‐pentamethyl‐4‐
bora‐3a,4a‐diaza‐s‐indacene,  Invitrogen)  and  36μM  bisbenzimide  (Sigma‐Aldrich),  then 
washed  with  KRB.  At  the  indicated  times,  Oil  Red  O  (ORO,  Sigma)  staining  of  the 
cytoplasmic droplets  of neutral  lipids was performed  according  to  a modification  from 
(Ramirez‐Zacarias J‐L, 1992 Histochemistry). Cells cultured in the bioreactor were rinsed, 
fixed with  10%  buffered  formalin,  stained with  0.3% ORO  in  isopropanol: water  (3:2), 
photographed  and  extracted with  4% Nonidet  (Sigma)/isopropanol. The  optical density 








TEM Cultures were fixed  in 2.5% glutaraldehyde  in 0.1 M phosphate buffer pH 7.4  for 
3h, post‐fixed with 1% osmium  tetroxide, dehydrated  in a graded series of ethanol, and 
embedded  in  araldite.  Semithin  sections were  stained with  toluidine blue  and used  for 








at  37°C  in  a  50μl  reaction  containing  1×RT  buffer,  150ng  random  hexamers,  0.5mmol/l 
deoxynucleotide  triphosphates, 20 U of RNAsin  ribonuclease  inhibitor and  200 U of M‐
MLV RT  (Promega Corporation, Madison, WI, USA). PCR was carried out using a DNA 
Engine Opticon 2 Continuous Fluorescence Detection System (MJ Research), all reactions 




To analyse PKCβ  translocation,  cells  seeded onto 24 mm glass  coverslips and grown  in 
LG‐DMEM  for  3  days were  fixed  in  4%  paraformaldehyde  solution  for  20min  at  RT, 
quenched with 0,1% glycine and permeabilized with 0.1% Triton X‐100  for 20min. After 
three  washes  with  PBS,  nonspecific  binding  sites  were  blocked  with  2%  BSA  for  1h. 





Intracellular  ROS  generation  was  measured  with  5‐(and‐6)‐chloromethyl‐2ʹ,7ʹ‐









To overexpress PKCβ,  the cells were  transduced  the day after seeding with a adenoviral 
vector expressing PKCβ‐GFP (AdEasy/PKCβ‐GFP). In the case of PKCβ overexpression in 
LG, we  observed  a  decrease  in  cell  viability  14  days  after  transfection,  that  affects  the 
evaluation  of  the  results.  To  evaluate  the  effect  of  PKCβ  in  LG, we  compared  in  this 
experiment  the  efficiency  of  differentiation  in  PKCβ‐expressing  and  control  cells  at  an 
earlier time point, in which overall differentiation was lower but there was no detectable 
reduction  in  cell  survival. PKCβ  silencing was  achieved by  infecting  cells  the day  after 
seeding with  a  commercially  available  lentiviral  siRNA  for PKCβ  (Sigma‐Aldrich),  at  a 
viral  titol  of  3.5  TU/ml  (TU:  transduction  units). As  a  control,  an  unrelated  gene was 





The  protocol  was  approved  by  the  Institutional  Animal  Care  Committee  of  Padua 
University.  8  female  Nude  rats  (Charles  River  Laboratories)  weighing  150‐200g  were 
subjected to the surgical procedures under halothane anesthesia and aseptic conditions. 4 





single  surgeon. The  animals were  fed  an unrestricted  standard diet. After  1,  2,  3  and  4 














































































































































































































































































































































































































































































































Akt/PKB      Protein Kinase B 




Coll I                  Type I Collagen 
Coll II     Type II Collagen 
DAG                  Diacylglycerol 
EM        Electron Microscopy 
ETC        Electron Transport Chain 
FHIT                  Fragile Histidine Triad 
FFA        Free Fatty Acids 
GLUT4      Glucose Transporter 4  
HG‐DMEM   High Glucose‐Dulbecco’s Modified Eagle Medium 
IRS1        Insulin Receptor Substrate‐1  
IR        Insulin Receptor 
IRS2        Insulin Receptor Substrate‐2  
LG‐DMEM                Low Glucose‐Dulbecco’s Modified Eagle Medium 
LPL        Lipoprotein Lipase  
MDSCs      Muscle‐Derived Stem Cells  
MHS        Melanocyte Stimulating Hormone 
mtGFP      Mitochondria‐Targeted Green Fluorescent Protein 
PEPCK       Phosphoenolpyruvate Carboxykinase 
PI3K        Phosphatidylinositol‐3‐OH Kinase  
PKC        Protein Kinases C  
PKCβ siRNA     Protein Kinase C β‐Small Interfering RNA 
PMA        Phorbol 12‐Myristate 13‐Acetate   
PPARγ      Peroxisome Proliferator Activated Receptor γ 
qRT‐PCR or RT‐PCR  (quantitative) Real‐Time RT‐PCR  
ROS        Reactive Oxygen Species  
SEM        Scansion Electron Microscopy 
SREBP1      Sterol Regulatory Element‐ Binding Protein 1  
TEM        Transmission Electron Microscopy 
VAT        Visceral Adipose Tissue 
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Regenerationofmesenchymal tissues depends ona resident stem cell
population, that in most cases remains elusive in terms of cellular
identity and differentiation signals. We here show that primary cell
cultures derived from adipose tissue or skeletal muscle differentiate
into adipocytes when cultured in high glucose. High glucose induces
ROSproduction andPKC activation. These twoevents appear crucial
steps in this differentiation process that can be directly induced by
oxidizing agents and inhibited by PKC siRNA silencing. The differ-
entiated adipocytes, when implanted in vivo, form viable and vascu-
larized adipose tissue. Overall, the data highlight a previously un-
characterized differentiation route triggered by high glucose that
drives not only resident stem cells of the adipose tissue but also
uncommitted precursors present in muscle cells to form adipose
depots. This processmay represent a feed-forward cycle between the
regional increase in adiposity and insulin resistance that plays a key
role in the pathogenesis of diabetes mellitus.
adipocyte  hyperglycemia  PKC  ROS
The identity and regulation of the adipocyte precursor cell is atopic of great interest and intense study. Microarray analyses
and functional genomics have revealed adipogenic transcriptional
signatures (1), but the signals occurring in pathophysiological
conditions and aging are still incompletely understood. Stem cells
are present in the adipose tissue and, under appropriate differen-
tiation, signals can differentiate in vitro in adipocytes or other
mesenchimal cells. Adipose-derived stem cells (ADSCs) represent
the key cellular element for the control of body adiposity and they
may substitute bone marrow-derived stem cells in their promising
applications for tissue repair and regeneration. Indeed, s.c. adipose
depots are accessible and abundant, thereby providing a potential
adult stem cell reservoir for each individual.
Further complexity is added by the observation that the adipose
depots of the body differ in functional properties, reflecting the
existence of different subpopulations of adipocytes. Visceral and
s.c. adipocytes release different endocrine mediators, collectively
called adipokines. Although both adipose depots are correlated
with metabolic risk factors, visceral adipose tissue remains more
strongly associated with an adverse metabolic risk profile, type 2
diabetes development, and an increased risk of coronary heart
disease (2). Even more intriguing is the role of intramyocellular
triglycerides and intramuscular fat, given that intramuscular fat
stores and substitution of muscle with adipose tissue have been
reported to strongly correlate with insulin resistance (3). Thus, in
the context of diabetogenesis (but also for other metabolic or
myodystrophic conditions), key biological issues are how intra- and
intermuscular adipose tissues originate and proliferate. Attention
has been recently focused on the transdifferentiation of muscle
progenitors to the adipogenic lineage, given thatmyopathic skeletal
muscle is characterized by the replacement of myofibers by adipose
tissue (4).
Muscle-derived stem cells (MDSCs) include the so-called satel-
lite cells, i.e., the precursor cells capable of differentiating in vivo to
mature muscle fibers and in vitro up to multinucleated skeletal
myotubes (5). Human satellite cells retain broad differentiation
capacity, including the generation of adipocytes in appropriate
culture conditions (adipogenic medium) in a process that is en-
hanced by the insulin sensitizer rosiglitazone (6). Activators of
PPAR- cause, in muscle, the induction of genes involved in fatty
acid uptake, storage, andmetabolism (7), and themyogenic cell line
C2C12 can be converted to adipocytes by overexpression of
PPAR- and C/EBP (8). As in hyperglycemia, high-glucose con-
centrations up-regulating sterol regulatory element binding protein
1c (SREBP-1c) induce de novo lipogenesis and intracellular lipid
accumulation in contracting myotubes (9).
We here demonstrate that both ADSCs and MDSCs differ-
entiate into adipocytes upon high glucose exposure. In this
process, an important role is attributed to reactive oxygen species
(ROS) and downstream effector kinases, such as PKC, recently
shown to act as signaling link between ROS and mitochondrial
targets implicated in age-dependent organ deterioration (10).
Results
High Glucose Induces Adipocyte Differentiation of Stem Cells from
Adipose Tissue.The isolation of ADSCs from human lipoaspirates
and their in vitro differentiation capacity into various mesenchi-
mal tissues was first established by using standard protocols. To
maximize nutrients delivery and to mimic the dynamic stress
conditions stimulating formation of extracellular matrix, ADSCs
were seeded onto hyaluronan-based sponge in a perfusion
system that allows the circulation of culture medium through the
scaffold (bioreactor). Further details on the isolation procedure
and bioreactor are given in Materials and Methods. Under these
conditions, the classical adipogenic, osteogenic, and chondro-
genic media were highly efficient in causing specific differenti-
ation into the expected cell lineage, as confirmed by morpho-
logical criteria (histological and electron microscopy analyses)
and molecular hallmarks. Similar data have been obtained by us
and others, using ADSC from mouse or rats, or using more
standard culture conditions (11). The procedures used and the
full characterization of the differentiated mesenchimal cells are
described in supporting information (SI) Fig. 6.
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The physiological stimuli that control ADSCs differentiation into
adipocytes in vivo remain unknown. We investigated whether one
of the most common conditions leading to an increase in adipose
tissue (12) in vivo, i.e., high-glucose concentration, can affect human
ADSCs differentiation into mature adipocytes in vitro (Fig. 1).
ADSCsweremaintained for 14 days in a low-glucose (LG)-DMEM
(i.e., DMEM, 10% FBS, and 5.5 mM glucose) or in a high-glucose
(HG)-DMEM (i.e., DMEM, 10% FBS, and 25 mM glucose), and
then analyzed by morphological (histochemistry, Fig. 1A, and
electron microscopy, Fig. 1 B and C) and molecular (Fig. 1D)
approaches. Staining with oil red O (ORO), selective for triglyc-
eride depots, revealed substantial adipose differentiation in cells
grown in HG-DMEM (Fig. 1Aii, 4.18  0.21 OD at 520 nm),
compared with cells grown in lower glucose DMEM (LG-DMEM)
(Fig. 1Ai, 2.16  0.11 OD at 520 nm). Accordingly, EM analysis
showed numerous cells with a typical adipocytic phenotype, i.e.,
containing large lipid droplets surrounded by a thin ring of cyto-
plasm (Fig. 1B). SEMmicroscopy showed a population of rounded
cells of various sizes, i.e., the typical appearance of adipose tissue
(Fig. 1C). The lower magnification (Fig. 1Ci) reveals the presence
of round adipocytes on both sides of the specimen.
In high-glucose conditions, RT-PCR analysis of mRNA tran-
scripts (Fig. 1D) revealed significant expression of adipocyte-
specific proteins, such as peroxisome proliferators activated recep-
tor gamma (PPAR), lipoprotein lipase (LPL), adiponectin,
glucose transporter 4 (GLUT4), and SREBP1c. Conversely, chon-
drogenic (type II collagen) and osteogenic markers (osteopontin,
osteonectin, and osteocalcin) were down-regulated in HG-DMEM
compared with cells cultured in LG-DMEM.
Adipogenic Conversion of Muscle-Derived Stem Cells on High Glucose.
We concluded that incubation in high glucose per se can drive the
differentiation of uncommitted stem cells into adipocytes, a previ-
ously uncharacterized mechanism for ADSCs (but see refs. 13 and
14 for pancreatic  cell lines). However, these stem cells were
derived from adipose tissue, and thus the observed effect could
represent the enhancement of the default differentiation route of
adipocyte precursors. To investigate whether it reflected conversely
the differentiation of uncommittedmesenchimal precursors or even
the transdifferentiation of stem cells of other mesenchimal tissues,
we turned our analysis to primary cultures of skeletal muscle. These
cells can be easily obtained from animal models, and thus the
following experiments were carried out on cells derived from
neonatal rats. Muscle-derived stem cells (MDSCs) from mouse or
rats can be differentiated into large myotubes, carrying most
phenotypic properties of skeletal muscle in terms of contractile
protein expression, morphological aspect (with diad and triad
formation), and signaling properties (5).
In the experiments shown in Fig. 2, we analyzed the effect of
HG-DMEMonMDSCs, using the standard culture conditions, i.e.,
in 100-mm Petri dishes. Parallel batches of cells were maintained in
LG-DMEM. In both cases, the medium was supplemented with
10% FCS (a conditions that prevents differentiation into myo-
tubes), and cells were maintained in culture for 18–25 days before
analysis. In LG-DMEM, as revealed by either counting the cells
with large vacuoles in the cytoplasm (Fig. 2Ai) or those positive for
the lipid specific dye 4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-
3a,4a-diaza-s-indacene (BODIPY) (Fig. 2Aii) the percentage of
cells with a morphological adipocyte phenotype was only 3.3 
2.4%. In HG-DMEM, a highly significant increase in adipocyte
differentiation was detected: 9.2 2.9% of the cells showed a clear
adipocytic phenotype, with either analysis methods (Fig. 2B), 2- to
4-fold higher than in LG-DMEM (HG: n  6; LG: n  4).
We then verified adipose differentiation efficiency in the 3D
scaffold of the bioreactor. MDSCs were thus seeded onto the
hyaluronan-based sponge and maintained in culture for 14 days
under LG-DMEM or HG-DMEM perfusion. Then, histochemical
and ultrastructural analyses of the cell culture were carried out. For
the former, five randomly chosen fields were analyzed for each
conditions, and the experiment was repeated with identical results
in three different trials. The results of a typical experiment are
presented in Fig. 2. In LG-DMEM, oil red O staining was hardly
detectable (Fig. 2Ci) although the cells became loaded with lipid
vesicles in HG-DMEM, as revealed by oil red O staining (Fig. 2Di);
quantification of oil red O-stained cells showed a marked higher
percentage of adipocytes in HG-DMEM (3.87  0.31 OD at 520
nm) compared with LG-DMEM (1.89  0.15 OD at 520 nm). In
agreement with these observations, electron micrographs showed
mostly elongated fibroblast-like cells in LG-DMEM (Fig. 2Cii) and
a high fraction of rounded cells with the typical mature adipocytes
appearance, in HG-DMEM (Fig. 2Dii). The percentage of cells
with an adipocyte phenotype obtained with HG-DMEM from
muscle cultures did not differ significantly from that observedunder
the same conditions, using ADSCs (3.87  0.31 OD at 520 nm in
MDSCs and 4.18 0.21 OD at 520 nm for ADSCs), indicating that
the differentiated adipocytes in the former case cannot derive from
a contamination from adipose tissue in the muscle cell cultures.
The adipogenic potential of high glucose on MDSCs was con-
firmed also by RT-PCR analyses of adipocyte-specific transcripts:
cells cultured in the bioreactor andmaintained inHG-DMEM(Fig.
2E) for 7 and 14 days, shown an higher expression of PPAR, LPL,
adiponectin, GLUT4, and SREBP1c and a down-regulation of
chondrogenic and osteogenic markers, compared with cells grown
in LG-DMEM. Expression of the adipocyte markers is shown in
Fig. 2E for 14 days of analysis. The comparison of theRT-PCRdata
at 7 and 14 days both for the ADSCs (Fig. 1) and the MDSCs (Fig.
2) is presented in SI Fig. 7.
Fig. 1. Adipose-derived Stem Cells (ADSCs) cultured on Hyaff 11 sponges in
LG- and HG-DMEM. (A) Oil red O staining of ADSCs grown in LG-DMEM (i) or
HG-DMEM (ii). Lipid droplets are in red, and biomaterial fibers in blue.
(Magnification: 20.) (B) Transmission electron microscopy (TEM) of two
representative fields. (Magnification: 6,500.) (C) Scanning Electron micros-
copy (SEM) of ADSCs at two different magnifications. (D) mRNA expression of
adipogenic, chondrogenic, and osteogenic markers analyzed after 14 days by
semiquantitative real time PCR in ADSCs cultured on 3D scaffolds in LG- and
HG-DMEM. Results for each condition are from quadruplicate experiments,
and values are expressed in relative units as the mean  SD. *, P  0.05.








Oxidative Stress by Effector PKCs Is a Trigger of Adipocytic Differen-
tiation. We decided to use this cell model to get some insight into
the mechanisms that drive high-glucose-induced adipocytic differ-
entiation. In the past years, major attention has been dedicated to
the induction of oxidative stress by high glucose (through three
mechanisms, NADP(H)oxidase, xanthine oxidase, and the mito-
chondrial respiratory chain) and its relevance for the development
of diabetes complications. Regarding the effector mechanisms,
PKC isoforms (PKC and PKC in particular) have been shown to
be activated by oxidizing conditions (10). We thus verified whether
these mechanisms represent the signaling route in stem cells
differentiation to adipocytes. We first measured ROS production
during high-glucose incubation. MDSC were obtained as in Fig. 2,
but the cells were seeded onto 24-mm glass coverslip for micro-
scopic analysis. Seven days after seeding, cells cultured in LG-
DMEM or HG-DMEM were loaded with the ROS-sensitive flu-
orescent probe CM-H2DCFDA. The coverslip with the cells was
transferred to the stage of a confocal microscope, and fluorescence
emission at 520 nm was monitored, revealing continuous ROS
production. The results, shown in Fig. 3A, demonstrated that ROS
production is markedly higher if the cell culture is maintained in
HG-DMEM.
We then verified whether this condition activates PKC, as
observed in endothelial cells (15). Endogenous PKC revealed by
immunofluorescence wasmostly cytosolic inMDSCsmaintained in
LG-DMEM(Fig. 3Bi). Incubation for 1 h in 25mMglucose induced
a partial translocation of the kinase to the plasma membrane in
30%of the cells (Fig. 3Bii), with a pattern similar to that observed
upon direct activation by phorbol 12-myristate 13-acetate (PMA)
(Fig. 3Biii).
The simplest interpretation of the data are that ROS produced
in response to high glucose, by stimulating PKC (and possibly
other effectors), act as a differentiation signal for adipogenic
conversion of MDSCs. We tested this hypothesis with three ap-
proaches: (i) LG-DMEM was supplemented with H2O2 to test
whether it could mimic the effect of high glucose and thus trigger
adipocytic differentiation; (ii) the cells, maintained inHG-DMEM,
were transduced with a vector carrying the PKC siRNA to test
whether this could inhibit adipocytic differentiation; and (iii) the
cells in HG-DMEMwere transduced with PKC expression vector
to verify whether its overexpression could synergize with high
glucose. The results presented in Fig. 4A (quantitated by counting
the percentage of BODIPY-loaded cells) strongly support the
hypothesis. In particular, (i) in LG-DMEM, addition of 100 M
H2O2 enhanced the differentiation rate to a level comparable to
that observed in high glucose (9.34  2.9% vs. 9.19  2.9%,
respectively) and no significant enhancement was detected if H2O2
was added to HG-DMEM (10.18  0.5%); (ii) PKC siRNA,
added to cells incubated in HG-DMEM, drastically reduced adi-
pocytic differentiation (80%) (Fig. 4A) to levels below those
found in LG-DMEM, whereas an unrelated siRNA (FHIT) had no
effect (5.5  0.5%); (iii) a major (300%) enhancement of lipid-
loaded cells was observed in cells overexpressing PKC and incu-
bated in HG-DMEM. Infection with a control viral vector (an
adenoviral vector expressing mtGFP) and PKC, per se, did not
increase adipocytic differentiation if added to cells in LG-DMEM
(data not shown). The same results were obtained by seeding
MDSCs onto hyaluronan base sponge of the bioreactor (Fig. 4B).
High-Glucose-Differentiated Adipocytes Can Be Successfully Im-
planted in Vivo. Finally, we verified whether in vitro-differentiated
adipocytes can generate mature and viable adipose tissue in vivo.
For this purpose, sponges enriched with ADSCs cultured in the
bioreactor for 7 days in high glucose, were implanted in the
abdominal area of eight female nude rats, as described inMaterials
and Methods. At 1, 2, 3, and 4 weeks after insertion of the graft, the
rats were killed and the grafts analyzed macroscopically (for color,
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Fig. 2. Highglucose induces adipocytedifferentiationofmuscle-derived stemcells (MDSCs). (AandB) Phase-contrast image (i) andBODIPY staining (ii) ofMDSCs
cultured in LG-DMEM (A) or HG-DMEM (B). (C and D) Oil red O staining (i) and SEM analysis (ii) of MDSCs cultured for 14 days on Hyaff 11 sponges in LG-DMEM
(C) and HG-DMEM (D). Lipid droplets are in red, and nuclei are in blue. (Magnification: 40). (E) Adipogenic, chondrogenic, and osteogenic markers mRNA
expression analyzed by semiquantitative real time PCR in MDSCs cultured on 3D scaffolds for 14 days in LG- and HG-DMEM. Results for each condition are from
quadruplicate experiments, and values are expressed in relative units as the mean  SD. *, P  0.05.
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scopically (for pore size, specific and unspecific cellularity, and
vascularity). The implant appeared well integrated in the s.c. tissue
and not surrounded by fibrotic tissue (Fig. 5Ai at 2 weeks and Fig.
5B at 3 weeks, white arrows). In addition, numerous capillaries (Fig.
5 Ai and Bi, blue arrows) revealed significant vascularization of the
engineered, reimplanted tissue. Harvesting of the sample con-
firmed that the sponge maintains its volume and soft consistence
and is easily dissected from the surrounding tissue (Fig. 5Aii).
Morphological characterization of the explants confirmed a
major distribution of preadipocytes over the whole cross-section
(Fig. 5C). Significant adipose tissue formation was detected (black
arrows) (Fig. 5C) already at 3 weeks. In most cases, the cells
exhibited the hallmarks of mature adipocytes, i.e., a large lipid
droplet surrounded by a thin ring of cytoplasm, with a flattened
nucleus located at the cell periphery. Adipocytes (Fig. 5C, black
arrows) were closely attached to the scaffold (red arrows), and
multiple capillaries were located near the preadipocytes and adi-
pocytes [Fig. 5 Ci and D (green arrows)].
Discussion
In this article, we investigated the effect of an increase in glucose
concentration on the differentiation route of stem cells residing in
both adipose tissue and skeletal muscle. In both cases, a clear
induction of adipogenic transformation was observed upon the
application of high-glucose culture conditions. The capacity of high
glucose to partly activate an adipogenic differentiation program
had already been noticed in pancreatic  cells (13, 14). In our case,
the process consists in a full conversion into adipocytes, as verified
by morphological and molecular criteria and the capacity of these
cultured cell to form viable and vascularized adipose depots when
implanted in vivo. In muscle-derived cells, the process appears to be
the genuine differentiation of uncommitted mesenchimal precur-
sors or a transdifferentiation of myogenic precursors. This conclu-
sion is supported by the following evidences: (i) when separate
cultures were prepared from upper- and lower-limb muscles (the
former may be partly contaminated by adipose tissue, whereas the
latter is virtually devoid of it), the efficiency of high-glucose-induced
adipocytic differentiation was very similar (upper limbs: 8.9 
2.7%; lower limbs 10.3  1.8%) and (ii) the percentage of differ-
entiated adipocytes induced by HG-DMEM is approximately the
same whether the culture was derived frommuscle or from adipose
tissue.
Adult skeletal muscle has a remarkable regenerative capacity,
largely mediated by satellite cells residing between the sarcolemma
and basal lamina of myofibers (16). The regenerative process and
proliferative capacity decrease as a function of age (17), partly for
the reduced activity of stimulatory factors (18), with consequent
loss of muscle mass. However, these alterations do not account for
other features of aged muscle, and, in particular, for the increased
lipid content (19). It has been reported that aged mice myoblasts,
comparedwith those from adultmice, show increased expression of
genes normally restricted to the adipocyte lineage (20), although a
fully differentiated adipocyte phenotype is not achieved. The
identification of a primary role of high-glucose exposure in adipo-
cytic differentiation has at least two major important conceptual
implications. It shows that high glucose per se has an adipogenic
potential, thus opening the search for signal transduction pathways
operating in obesity and diabetes. Second, a direct link between
hyperglycemia and the increase in adiposity highlights a feed-
forward cycle, which may play a key role in the progression of the
metabolic dysfunction into an irreversible diabetic state.
Regarding the signals driving the differentiation of muscle stem
cells into adipocytes, our data suggest a crucial role for reactive
oxygen species (ROS). Interestingly, among the cellular conse-
quences of high glucose, increased production ofROS is recognized
as a major cause of the clinical complications associated with
diabetes and obesity (21). Various mechanisms appear to synergize
in increasing ROS production, ranging from the activity of mito-
chondrial respiratory complexes to the activation of enzymatic
systems, such as NOX isoforms, NO synthase, and xanthine oxidase
(22). Despite the presence of scavenging systems (e.g., superoxide
dismutase and catalase), the damaging effects of ROS have been
proposed to be responsible for progressive organ degeneration (23).
However, the role of ROS is not only restricted to cell damage
induction. Indeed, ROS may directly regulate the activity of tran-

























































Fig. 3. ROS production of MDSCs cultured in LG- and HG-DMEM and
glucose-induced PKC-activation. (A) Seven days after seeding, cells were
loaded with the CM-H2DCFDA and analyzed by confocal microscopy. Basal
ROS production is expressed as mean of CM-DCF oxidation rate (fluorescent
arbitrary units per second). Representative traces of CM-DCF oxidation kinet-
ics are shown at Right (black, high-glucose condition; gray, low-glucose
condition). (B) PKCmembrane translocation, as revealed by immunofluores-
cence microscopy. Representative images show cells maintained in LG-DMEM
(i), incubated for 1 h in HG-DMEM (ii), and treated with 500 nM PMA (iii). The
graphs show the quantitation of PKC fluorescence intensity along a line
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Fig. 4. Quantitation of MDSCs adipocyte differentiation in different condi-
tions. (A) MDSCs cultured in different conditions: HG-DMEM, LG-DMEM,
LG-DMEM supplemented with 100 M H2O2, PKC-overexpression in HG-
DMEM,andPKC siRNA inHG-DMEM.TheefficiencyofMDSCsdifferentiation
was quantitated by counting the percentage of BODIPY-loaded cell. The
histogram shows thepercentageofdifferentiation SEM. (B)MDSCs cultured
on Hyaff 11 sponges in LG-DMEM supplemented with 100 M H2O2 (i),
PKC-overexpression in HG-DMEM (ii), and PKC siRNA in HG-DMEM. Adipo-
genic differentiationwas confirmed by oil redO staining. Lipid droplets are in
red, and nuclei are in blue. (Magnification: 10.)








tory gene expression (24). Our results add an important conceptual
mechanism by revealing amorphogenetic signaling activity of ROS.
In fact, ROS, through downstream effectors and in particular
through PKC (as revealed by the strong inhibitory effect of siRNA
and by the strong synergism of high glucose with PKC overex-
pression), lead to the neoformation of adipose cells. In turn,
adipocytes are known to release adipokines that regulate, among
other targets, the insulin sensitivity of peripheral tissues (25). A
similar role is in keeping with previous reports showing a role of
ROS in embryogenesis (see, for example, the role of NOX4 in
promoting the spontaneous beating of cardiac cells within embryoid
bodies of mice) (26).
Finally, the present data provide additional support to the role of
PKCs in detecting high-glucose conditions and sustaining the
ROS-mediated signaling route. This result well agrees with a
number of previous observations that on the one hand highlighted
an important role for PKC in diabetes and in adipogenesis and on
the other established a link between PKCs, ROS production, and
cell degeneration (27). Indeed, PKC isoforms have been shown to
translocate to the plasma membrane of endothelial cells upon
high-glucose culture conditions (15) and to play an important role
in the pathogenesis of diabetes complications. It has been recently
reported that PKC- muscle-specific knockout mice recapitulate
most of the features of the metabolic syndrome including impaired
glucose tolerance or diabetes, islet  cell hyperplasia, and abdom-
inal adiposity (28). In this case, the key dysfunction appears to be
the impairment of GLUT4-mediated glucose transport across the
plasma membrane of skeletal muscle, with ensuing release of anti
insulinic factors and, thus, insulin resistance. In turn, insulin resis-
tance and hyperinsulinemia can trigger abdominal obesity and
adipose tissue growth in extra adipose sites such the intramuscular
site. In addition to these metabolic effects, PKCs appear to be
involved in detecting and decoding a variety of stress conditions,
including oxidative challenges. We recently showed that PKC
recruits the 66-kD proapoptotic isoform of Shc (p66Shc) to act as
oxidoreductase within mitochondria (29) and in triggering a feed-
forward cycle of ROS production eventually leading to cell death
(10). The same actors may come together in a radically different
context, i.e., the production of cellular signals linking hyperglicemia
to the regulation of a transdifferentiation scheme of stem cells
residing in insulin target tissues. How the same signaling route can
trigger uncommitted stem cell differentiation or induce apoptosis
remains to be elucidated. Here, we can only stress that the toxicity
and the differentiation effects of H2O2 are optimally observed at
different concentrations, i.e., 1 mM and 100 M, respectively.
In conclusion, we demonstrate that high glucose has an adipo-
genic potential on stem cells derived from both the adipose tissue
and skeletal muscle, and we provide some insight into the signals
and molecules that underlie this process. These results may deepen
our understanding of the pathogenesis of type 2 diabetes and
highlight potential targets for pharmacologically addressing this
disease of dramatic social impact.
Materials and Methods
Cell Cultures. Muscle-derived stem cells. Primary cultures of muscle-derived stem
cells (MDSCs) were prepared from newborn rats (2–3 days) as described in ref. 5.
Adipogenic conversion was observed both in the first preplating (15 min or 2 h)
and in the replating of non-rapidly adherent cells. In the latter case, a small
fraction ofmyotubes was still present, and their contraction in culturemade the
cell yieldhighlyvariable. For thispurpose, thefirstpoolofadherentcellswasused
for all experiments.
Adipose-derived stem cells. Adipose-derived stem cells (ADSCs) were extracted
fromhumanadipose tissuesoffivehealthy femalepatients undergoing cosmetic
surgery procedures, following guidelines from the Clinic of Plastic Surgery, Uni-
versity of Padova. Adipose tissues were digested with 0.075% collagenase (type
1A; Sigma–Aldrich) in Krebs–Ringer buffer (modified KRB) [125 mMNaCl, 5 mM
KCl, 1mMNa3PO4, 1mMMgSO4, 5.5mMglucose, and20mMHepes (pH7.4)] for
60min at 37°C followed by 10minwith 0.25% trypsin. Floating adipocytes were
discarded, and cells from the stromal-vascular fractionwerepelleted, rinsedwith
media, and centrifuged, and a red cell lysis step in NH4Cl was done for 10min at
room temperature. The viable cells obtainedwere counted by using trypan blue
exclusionassayand seededatadensityof 10105 cells per square centimeter for
in vitro expansion.
Biomaterials. Spongesmade of Hyaff 11, a linear derivative of hyaluronic acid,
in which the carboxylic function of the monomer glucuronic acid in the
hyaluronic acid chain is totally esterifiedwith benzyl groups,were supplied by
Fidia Advanced Biopolymers. The structure of these sponges shows open
interconnecting pores. Sponges were provided as cylinders. All carriers were
sterilized by -irradiation before use.
Adipocyte Differentiation Detection. To quantitate adipocyte differentiation,
Petridish-culturedcells atdays18–25were loadedfor10minwith40MBODIPY
493/503 (4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene; In-
vitrogen) and 36 M bisbenzimide (Sigma–Aldrich), then washed with KRB. At
the indicated times, oil red O (ORO) (Sigma–Aldrich) staining of the cytoplasmic
dropletsofneutral lipidswasperformedaccordingtoamodificationfromref.30.
Cells cultured in the bioreactor were rinsed, fixed with 10% buffered formalin,
stainedwith0.3%ORO in isopropanol:water (3:2), photographed, andextracted
with 4% Nonidet (Sigma–Aldrich) and isopropanol. The optical density (OD) of
the solution was measured at 520 nm for quantification, using a Victor 3 spec-
trometer (Perkin–Elmer).
Electron Microscopy. SEM. Samples of reconstructed adipose tissues were fixed
with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 1 h before being
processed either with hexamethyldisilazan or at the critical point followed by
gold-palladium coating. All micrographswere obtained at 30 kV on a JEOL 6360
LV SEMmicroscope.
TEM. Cultures were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer pH
7.4 for 3h, postfixedwith1%osmiumtetroxide, dehydrated inagraded series of
ethanol,andembeddedinaraldite.Semithinsectionswerestainedwithtoluidine
blue and used for lightmicroscopy analysis. Ultrathin sections were stainedwith
uranyl acetate and lead citrate and analyzed with a Philips EM400 electron
microscope.
Real-Time RT-PCR and Quantitative RT-PCR. Total RNA was extracted by using a
kit (RNeasyMini;Qiagen) according to the supplier’s instructions. RNA (1g)was
treated with DNase (Ambion) and reverse-transcribed for 1 h at 37°C in a 50-l
reaction containing 1 room temperature buffer, 150 ng of random hexamers,
0.5 mmol/liter deoxynucleotide triphosphates, 20 units of RNAsin ribonuclease













Fig. 5. Macro and microscopic analyses of in vitro-differentiated adipocytes
implanted in vivo. (A and B) Macroscopic aspect 2 (A) and 3 (B) weeks after
implantation of the Hyaff 11 sponge seeded with adipocytes in HG-DMEM. (Ai
and Bi) Images of the implanted tissue in situ. (Aii) Image of the graft after
dissection. (Bii) Low-magnification image of the four implanted grafts. (C andD)
Histological analyses of the grafts 3 weeks after implantation. Haematoxilin/
eosinstainingofnewlyformedtissues is shown. (Magnification:Ci,20;Cii,40.)
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DNAEngineOpticon2Continuous FluorescenceDetectionSystem(MJResearch).
All reactions were performed twice. Results were normalized by
beta2microglobulinmRNA and reported as arbitrary units. The sequences of the
primers are available upon request.
Analysis of PKC Translocation. Toanalyze PKC translocation, cells seededonto
24-mm glass coverslips and grown in LG-DMEM for 3 days were fixed in 4%
paraformaldehyde solution for 20 min at room temperature, quenched with
0.1% glycine, and permeabilized with 0.1% Triton X-100 for 20min. After three
washes with PBS, nonspecific binding sites were blocked with 2% BSA for 1 h.
Immunostainingwasperformedwiththemonoclonalmouseanti-PKCII primary
antibody (diluted 1:20 in 2% BSA), followed by the visualization with the Alexa
Fluor 488 anti-mouse antibody (Molecular Probes).
Measurements of ROS Production. Intracellular ROS generation was measured
with 5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2DCFDA) (Invitrogen), which is cell-permeant. After ester hydrolysis,
the probe is trapped as a nonfluorescent probe, 5-(and-6)-chloromethyl-2,7-
dichlorodihydrofluorescein. After its oxidation by ROS, 5-(and-6)-chloromethyl-
2,7-dichlorofluorescein (CM-DCF) green emission was recorded at 520 nM.
Cells were loadedwith 10MCM-H2DCFDA at 37°C inmodified KRB at 5.5 or
25 mM glucose. After 30 min, laser scanning confocal microscopy images were
obtained. Acquisitions were made every 1 s for 500 s.
PKC Overexpression and Silencing. To overexpress PKC, the cells were trans-
duced the day after seeding with a adenoviral vector expressing PKC-GFP
(AdEasy/PKC-GFP). In the case of PKC overexpression in LG, we observed a
decrease incell viability14daysafter transfection,whichaffects theevaluationof
the results. To evaluate the effect of PKC in LG,we compared in this experiment
the efficiency of differentiation in PKC-expressing and control cells at an earlier
time point, in which overall differentiation was lower but there was no detect-
able reduction in cell survival. PKC silencing was achieved by infecting cells the
dayafter seedingwitha commercially available lentiviral siRNAforPKC (Sigma–
Aldrich), at a viral titol of 3.5 transduction units per milliliter. As a control, an
unrelated gene (FHIT) was silenced, because a siRNA scrambled mixture was
shown (31) and confirmed in our studies to enhance adipocyte differentiation.
Surgical Implantation of Hyaluronic Acid Sponges Seeded with Adipocytes. The
protocol was approved by the Institutional Animal Care Committee of Padua
University. Eight female nude rats (Charles River Laboratories), weighing 150–
200g,were subjected to the surgicalproceduresunderhalothaneanesthesiaand
aseptic conditions. Four Hyaff 11 sponges seeded with adipocytes in HG-DMEM
were implanted in the abdominal area. Throughout four small (0.3-cm) skin
incisions, the sponges were inserted in a s.c. pocket above the abdominal fascia.
Skin incisions were closed with one nylon 5-mm stitch. No anticoagulants were
used before or after the operation, and no prophylactic antibiotic was adminis-
tered. All surgical procedures were performed in the same way by a single
surgeon. The animals were fed an unrestricted standard diet. After 1, 2, 3, and 4
weeks, two ratswere killed by an overdose of gaseous anesthetic, and the grafts
were explanted.
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